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Summary 
Mitotic phosphatases play crucial roles in anaphase regulation and mitotic exit by 
annulling the kinase-mediated protein phosphorylation. In budding yeast 
Saccharomyces cerevisiae, Cdc14 (cell division cycle 14) phosphatase antagonizes key 
Cdk1 (cyclin-dependent kinase 1) functions to drive cells out of mitosis. Despite the 
presence of highly conserved catalytic domains, human CDC14s are dispensable for 
cell cycle progression. Nevertheless, to decipher the molecular mechanisms of 
human CDC14s functions, we have investigated the knockout cellular models aided 
by various imaging and proteomics approaches. Phenotypic analyses of the 
generated hCDC14A knockout in human retinal pigment epithelium (hTERT-RPE1) 
cells have exhibited the occurrence of longer primary cilia upon serum starvation. 
The intermediate longer cilia in haploid-insufficient cells, as well as the extended 
cilia observed upon siRNA-mediated acute depletion of hCDC14A, have further 
confirmed the phenotype. Primary cilia are microtubule-based structures that control 
various aspects of growth and development through sensing extracellular signals. 
Defects in this regulation lead to a host of pathological conditions collectively known 
as ciliopathies. Indirect immunofluorescence and electron microscopy have revealed 
that the disassembly pathways, as well as the crucial structures like axoneme and 
basal body, were intact in the elongated cilia. Inducible expression of hCDC14A has 
indicated its presence in the proximal end and subdistal appendage of the basal 
body. Global phosphoproteome along with proximity-based interaction proteomics 
approaches under conditions that favor ciliation have identified substrates for 
hCDC14A. Some of the identified substrates are involved in actin cytoskeleton 
reorganization with a function in cilia length control. The actin bundling protein 
drebrin (DBN1) was one of the identified hCDC14A substrates that have recently 
been reported to be associated with ciliogenesis. We show that the counteracting 
phospho-regulation of DBN1 at serine residue 142 by the proline directed kinase 
CDK5 and hCDC14A phosphatase regulates cilia length. However, significantly 
longer cilia in hCDC14A knockout cells than those from DBN1 knockout cells 
indicate that there are more substrates for hCDC14A that might be involved in 
ciliogenesis. The longer cilia phenotype in hCDC14A knockout cells could be 
explained by the enhanced recycling endosomes (transferrin) as well as increased 
ciliary vesicle docking (smoothened) in the pericentrosomal areas. 
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Zusammenfassung (Summary in German) 
Mitotische Phosphatasen spielen eine entscheidende Rolle bei der Regulierung der 
Anaphase und dem Austritt aus der Mitose durch die Aufhebung der Kinase-
vermittelten Proteinphosphorylierung. In der Bäckerhefe Saccharomyces cerevisiae 
wirkt Cdc14 (Cell division cycle 14) den Schlüsselfunktionen von Cdk1 (Cyclin-
dependent kinase 1) entgegen, um die Mitose abzuschließen. Trotz hoch 
konservierter katalytischer Domänen sind humane CDC14 Phosphatasen für die 
Zellzyklus-Progression nicht essentiell. Um die molekularen Funktionsmechanismen 
der humanen CDC14 Phosphatasen zu entschlüsseln, haben wir Knockout-
Zellmodelle mittels verschiedener bildgebenden und proteomischen Verfahren 
untersucht. Phänotypische Analysen des erzeugten hCDC14A-Knockouts in 
humanen retinalen Pigmentepithelzellen (hTERT-RPE1) zeigten das Auftreten 
längerer primärer Zilien nach Serumentzug. Die intermediär längeren Zilien in 
haploid-insuffizienten Zellen sowie die längeren Zilien, die nach siRNA-vermittelter 
akuter Depletion von hCDC14A beobachtet wurden, haben den Phänotyp weiter 
bestätigt. Primäre Zilien sind Mikrotubuli-basierende Strukturen, die verschiedene 
Aspekte des Wachstums und der Entwicklung durch Wahrnehmung extrazellulärer 
Signale kontrollieren. Fehlfunktionen in dieser Regulierung führen zu einer Vielzahl 
von pathologischen Veränderungen, die als Ziliopathien zusammengefasst werden. 
Indirekte Immunofluoreszenz und Elektronenmikroskopie haben gezeigt, dass 
Abbauwege sowie wichtige Strukturen wie das Axonem und der Basalkörper in den 
verlängerten Zilien intakt sind. Induzierte Expression von hCDC14A wies auf die 
Präsens im proximalen Ende und subdistalen Appendix des Basalkörpers hin. 
Globale Phosphoproteom- und auf Proximität beruhende Proteomik-Analysen unter 
Bedingungen, die die Ziliation begünstigen, haben Substrate für hCDC14A 
identifiziert. Einige der identifizierten Substrate sind an der Reorganisation des 
Aktin-Zytoskeletts beteiligt, einhergehend mit einer Funktion bei der 
Längenkontrolle von Zilien. Das Aktin-bündelnde Protein Drebrin (DBN1) ist eines 
der identifizierten hCDC14A-Substrate, das kürzlich in Zusammenhang mit 
Ziliogenese gebracht wurde. Wir zeigen, dass die entgegenwirkende 
Phosphoregulierung von DBN1 am Serin-Rest 142 durch die Prolin-gerichtete Kinase 
CDK5 und der Phosphatase hCDC14A die Zilienlänge reguliert. Signifikant längere 
Zilien in hCDC14A-Knockout-Zellen als in DBN1-Knockout-Zellen weisen jedoch 
darauf hin, dass es weitere Substrate für hCDC14A gibt, die an der Ziliogenese 
beteiligt sein könnten. Der Phänotyp mit längeren Zilien in hCDC14A-Knockout-
Zellen könnte durch ein erhöhtes Aufkommen von Recycling-Endosomen 
(Transferrin) sowie durch ein gesteigertes Andocken ziliarer Vesikel (Smoothened) 
in den perizentrosomalen Bereichen erklärt werden. 
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1 Introduction 
1.1 An overview of cell cycle 
Cells multiply through a precise series of events that are collectively termed as cell 
cycle (Temin, 1971). Most of the time, cells stay in G1 or GAP1 phase during which 
they resume biosynthesis to accumulate nutrients and components necessary for 
DNA synthesis during the next phase termed as S or Synthesis phase. However, if 
the conditions are not conducive to growth, the cells can be arrested in G1 and enter 
a special phase of no growth termed as G0 or GAP0 (Pardee, 1974). When the 
environmental (presence of nutrients and growth factors) and internal (absence of 
damages) conditions are fulfilled, the cells passage through G1 and accomplish S 
phase. S phase is followed by another gap phase, GAP2 or G2, which allows cells to 
check the integrity of cell components as well as newly synthesized genetic material 
and to duplicate the necessary cell organelles. Chromosome segregation 
(karyokinesis) and cell division (cytokinesis) occur during M phase. Mitosis is 
divided into 5 stages: prophase, prometaphase, metaphase, anaphase, and telophase. 
Condensation of chromatin as well as the breakdown of nuclear envelope occurs 
during prophase. Condensed sister chromatids congress during prometaphase and 
align at the equatorial plate of the bipolar spindle in metaphase which is followed by 
anaphase that ensures proper separation of the sister chromatids to the opposite 
spindle poles. Cells exit Mitosis through telophase during which reassembly of 
nuclear envelope and decondensation of chromosomes occur (Baserga, 1968; 
Hartwell and Weinert, 1989). 
The centrosome serves as the key microtubule-organizing center (MTOC) in 
animal cells. It is composed of a microtubule based structure called centriole 
embedded into a protein-rich material organized in concentric circles (pericentriolar 
matrix, PCM) (Conduit et al., 2015; Mardin and Schiebel, 2012). Centrosome 
biogenesis, as well as maturation, is tightly coupled to cell cycle events and it 
duplicates once per cell cycle like cellular genetic material (Figure 1.1). In S phase, a 
daughter centriole is formed perpendicular to pre-existing mother centriole and 
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remain tightly engaged with each other throughout S, G2 and M phase. During S-G2 
phases, the centrosomes maturate by accumulating more PCM with concomitant 
elongation of the linkers connecting them. Eventually, at G2/M transition, the 
centrosomes separate by the dissolution of linker and migrate towards opposite 
poles to form bipolar spindle necessary for sister chromatid separation. After 
mitosis, the mother-daughter disengagement occurs at G1 phase by the 
establishment of linker between them. The disengaged centrioles duplicate in S 
phase to initiate the formation of two mature centrosomes at G2/M transition 
(Agircan et al., 2014; Bettencourt-Dias and Glover, 2007). 
 
 
Figure 1.1: The close association between centrosome and cell cycle in animal cells 
(Adopted from Mardin and Schiebel, 2012). 
Centrosomes are the key organelle for bipolar spindle formation in mitosis and, like 
cellular genetic material, are duplicated once per cell cycle.  
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1.2 Regulation of Cell cycle 
Highly dynamic, yet tightly controlled, protein phosphorylation and de-
phosphorylation events are important avenues to achieve unidirectional and precise 
division of cell components. Opposing kinases and phosphatases are the cellular 
tools to control these processes in a spatial and temporal manner. Cyclin-dependent 
kinases (Cdks) lie at the heart of cell cycle control system and their activities rise and 
fall as the cell progresses through the cell cycle (Morgan, 1997). These fluctuations 
directly correspond to cyclical changes in the phosphorylation of cellular proteins 
and thereby lead to the initiation and accomplishment of cell-cycle events. Cyclin-
dependent kinases (CDKs) are serine/threonine kinases which require cyclin(s) for 
enzymatic activity. The CDK family in mammals have diverse functions and can be 
subdivided into three cell-cycle-related subfamilies (Cdk1, Cdk4 and Cdk5) and five 
transcriptional subfamilies (Cdk7, Cdk8, Cdk9, Cdk11 and Cdk20) (Lim and Kaldis, 
2013; Malumbres, 2014). Cdk5 is considered to be an atypical membrane- anchored 
CDK. It is activated by the non-cyclin proteins Cdk5R1 (p35) or Cdk5R2 (p39) and  
T-loop phosphorylation is not required (Arif, 2012; Cheung and Ip, 2012). CDK5 is 
thought to be active in terminally differentiated cells such as neurons because of the 
expression pattern of p35 and p39. However, apart from its critical role in neurons, 
Cdk5 take part in other cellular processes ranging from migration to cytoskeletal 
dynamics (Arif, 2012; Cheung and Ip, 2012; Lim and Kaldis, 2013).  
Several molecular mechanisms including post-translational protein 
modifications and regulated degradation ensure the sequential phase-specific 
activation/inactivation of Cdks. Thus, it can be convincingly presumed that mitotic 
phosphatases play pivotal roles in annulling the kinase-mediated protein 
phosphorylation. However, our current knowledge regarding the regulation as well 
as substrate-specificity of most of the phosphatases is still in its infancy. 
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1.3 Phosphatases in animal cells 
The kinases and their counteracting phosphatases orchestrate the protein 
modifications associated with precise cell cycle phases (Barr et al., 2011). Interference 
with either kinase or phosphatase activity will affect orderly mitotic progression 
(Heinrich et al., 2002). The phosphatases expressed in human can be divided into 
two prominent groups depending on the amino acids that they dephosphorylate: (a) 
protein tyrosine phosphatase (PTP) family and (b) serine/threonine-specific 
phosphatases (PSTPs) family (Tonks, 2006; Trinkle-Mulcahy and Lamond, 2006). 
PTP family includes the dual-specificity tyrosine and serine/threonine phosphatases 
(DUSPs) and, with the exception of Cdc25, PTPs are involved in cellular signal 
transduction rather than in the regulation of mitosis. The PSTPs can be further 
classified into two groups that are both dependent on metal ions for catalysis: (a) 
PPM family of metallo-dependent phosphatases and (b) phospho-protein 
phosphatases (PPP) family (Kumagai and Dunphy, 1991). PPP family includes the 
phosphatases PP1, PP2A, PP2B, PP4, PP5, PP6, PP7 and are the key regulators for 
cell division (Axton et al., 1990; Picard et al., 1989) (Figure 1.2). Treatment of PPP 
specific inhibitor okadaic acid is sufficient to trigger mitotic changes such as 
chromatin condensation and organelles rearrangement, indicating the critical 
opposing role of PPP in mitotic entry (Lucocq et al., 1991; Yamashita et al., 1990). 
PPP phosphatases function as multimeric holoenzyme complexes consisting of a 
catalytic subunit and one or more of a number of associated regulatory and 
scaffolding subunits (Barr et al., 2011). 
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Figure 1.2: Phospho-protein phosphatases (PPP) family are the key regulators of 
cell cycle progression in animal cells (Adopted from Barr et al., 2011).  
Cell cycle dependent rise and fall of key kinase/ phosphatase levels/activity are 
depicted with respective coloured lines. The balance between kinases and 
phosphatases determines the cell cycle progression. 
 
1.4 Cdc14 phosphatase in budding yeast 
CDC14 (cell division cycle 14) belongs to the dual-specificity phosphatases family 
and is essential for cell cycle progression in budding yeast Saccharomyces cerevisiae 
(Hartwell et al., 1973). It is the master regulator of cell cycle completion in yeast 
(Amon, 2008) and mutants of Cdc14  arrest in late anaphase with duplicated, 
separated chromosomes and elongated spindles (Pringle and Hartwell, 1981). 
ScCDC14 is a proline-directed dual specificity phosphatase (serine/threonine) which 
prefers pSPxK/R sites for substrates (Bremmer et al., 2012; Eissler et al., 2014). 
CDC14 dephosphorylates and activates Cdh1, which in turn causes the degradation 
of Clb2 in an APCCdh1 (anaphase-promoting complex) dependent manner. Cdc14 
also augments the synthesis of Cdk-Clb2 inhibitor Sic1 through dephosphorylation 
mediated activation of the transcription factor Swi5. Moreover, Sic1 is stabilized by 
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CDC14  (Feldman et al., 1997; Jaspersen et al., 1999; Knapp et al., 1996). Thus, 
ScCDC14 antagonizes the Cdk1 functions to sharpen the metaphase to anaphase 
transition (Stegmeier and Amon, 2004). 
During the whole interphase and up to the anaphase, ScCDC14 is trapped inactive in 
the nucleolus through the components of RENT (REgulator of Nucleolar silencing 
and Telophase exit) complex including Net1, Sir2 (a NAD-dependent deacetylase), 
Tof2, and Fob1 (Shou et al., 1999). Net1, a protein that directly binds to rDNA, is 
required for the nucleolar localization of ScCdc14 (Huang and Moazed, 2003; 
Straight et al., 1999). Release from the nucleolus and activation of ScCdc14 occur in 
two sequential waves: the Fourteen Early Anaphase Release (FEAR) network and the 
Mitotic Exit Network (MEN) (Amon, 2008; Queralt and Uhlmann, 2008; 
Wurzenberger and Gerlich, 2011) (Figure 1.3).  
 
 
Figure 1.3: The regulatory networks that activate Cdc14 in budding yeast (Adopted 
from Wurzenberger and Gerlich, 2011). 
The Cdc14 early anaphase release (FEAR; yellow) and mitotic exit network (MEN; 
light blue), regulatory networks activate Cdc14 for budding yeast mitotic exit. FEAR 
causes the early anaphase partial release whereas MEN leads to the complete release 
of CDC14 necessary for the completion of mitotic exit (Wurzenberger and Gerlich, 
2011). 
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The FEAR network causes the hyperphosphorylation of Net1 by Cdk1 and 
Cdc5 (a Polo-like kinase) to cause a partial release of ScCDC14. The APCCdc20 is 
activated upon spindle assembly checkpoint (SAC) satisfaction and leads to the 
proteasomal degradation of securin, thereby allowing separase to inactivate PP2A–
Cdc55 and inhibit Net1 dephosphorylation. The MEN network ensures the complete 
CDC14 release by a pathway involving the small GTPase Tem1. The function of 
Tem1 is regulated by the GTPase-activating protein (GAP) Bfa1–Bub2, and the 
putative guanine nucleotide exchange factor (GEF) Lte 1 (low temperature essential 
1). Tem1 regulates the phosphorylation of Net1 by several downstream MEN 
kinases, including Cdc15 and the kinase complex Mob1–Dbf2 (Wurzenberger and 
Gerlich, 2011). 
 
 
Figure 1.4: Schematic representation of Cdc14 primary structures (Adopted from 
Mocciaro and Schiebel, 2010). 
The N-terminal conserved domains are shown in red and the variable C-terminals are 
shown in light blue. The nucleolar targeting sequence in green; catalytic motif in 
yellow; NLS (nuclear localization signal) in dark blue; NES (nuclear export signal) in 
orange. Here, ScCdc14: Budding yeast Cdc14; Clp1: Fission yeast Cdc14-like 
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phosphatase (Clp1); CeCdc14: C. elegans Cdc14; XCdc14A/B: Xenopus Laevis 
Cdc14A/B; cCdc14A/B: Chicken Cdc14A/B) (Mocciaro and Schiebel, 2010). 
 
 
1.5 Cdc14: a family of conserved phosphatases  
The Cdc14 family of phosphatases is highly conserved in almost all higher 
eukaryotes including Saccharomyces cerevisiae, Schizosaccharomyces pombe, 
Caenorhabditis elegans, Xenopus laevis, Gallus gallus and Homo Sapiens (Mocciaro and 
Schiebel, 2010) (Figure 1.4). Schizosaccharomyces pombe and Caenorhabditis elegans 
possess only one gene coding for an ortholog of ScCdc14. The ortholog of ScCDC14 
in fission yeast Saccharomyces pombe is non-essential and is known as Cdc14-like 
phosphatase (Clp1) (Trautmann et al., 2001). Although Clp1 and ScCDC14 share 36% 
sequence identity, the role of Clp1 in cell-cycle control is different than its budding 
yeast ortholog. Clp1 mainly controls mitotic entry and coordinates cytokinesis with 
the initiation of the next cell cycle. It is not crucial for mitotic exit  (Cueille et al., 
2001; Trautmann et al., 2001). Clp1 localization in nucleolus during G1/S phase is 
similar to that of ScCDC14. However, unlike ScCDC14, Clp1 is released at the G–M 
transition and is independent of MEN and FEAR pathway activation (Chen et al., 
2006). After release, Clp1 associates with kinetochore and functions in collaboration 
with Aurora B kinase to ensure accurate chromosome segregation (Trautmann et al., 
2001). During cytokinesis, Clp1 regulates the septum formation. Nevertheless, it is 
not essential for either septation or cytokinesis (Clifford et al., 2008; Cueille et al., 
2001; Khmelinskii et al., 2009; Simanis, 2003; Trautmann et al., 2001).  
Vertebrates such as humans, primates, mice, chickens, and fish were reported 
to have two genes coding for CDC14 phosphatases, CDC14A and CDC14B, with 
high degree of sequence homology to ScCDC14 (Clément et al., 2011, 2012; Li et al., 
1997; Mocciaro and Schiebel, 2010; Rosso et al., 2008; Wei et al., 2011). A 
retroduplication event of CDC14B gene (from Chromosome 9 to 7) generated a third 
gene (CDC14C) coding for a member of CDC14 family in hominoids around 18–25 
million years ago (Rosso et al., 2008). CDC14C was reported to be transcribed only in 
brain and testis (Brawand et al., 2011) (Figure 1.5). 
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Figure 1.5: Expression of Cdc14 isoforms in different organs of human body. 
Degree of expression in TPM (transcript per million) are represented by the intensity 
of blue colour. The expression data was retrieved from the expression atlas 
(https://www.ebi.ac.uk/gxa/home/). The ‘Mammalian Kaessmann` data from eight 
different human tissues are used in the graph (Brawand et al., 2011).  
 
1.6 Functions of hCDC14 proteins 
Human cells encode three paralogs of hCDC14, namely hCDC14A, hCDC14B and 
hCDC14C (Li et al., 2000; Rosso et al., 2008). In spite of the high conservations 
between the catalytic domain of all CDC14 phosphatases (Gray et al., 2003) and the 
complementation of ScCDC14 by hCDC14B (Cho et al., 2005), human CDC14s have 
so far been reported to be involved in functions that are more diverse than that of 
budding yeast (Mocciaro and Schiebel, 2010). hCDC14A was proposed to exert its 
function at centrosome duplication (Mailand et al., 2000) and actin cytoskeleton 
regulation (Chen et al., 2017, 2016) while hCDC14B was implicated in mitotic 
progression (Tumurbaatar et al., 2011), DNA damage checkpoint activation and 
DNA repair (Bassermann et al., 2008; Lin et al., 2015). Nevertheless, hCDC14B 
depleted human cells display normal mitotic exit and cytokinesis (Berdougo et al., 
2008). Moreover, the viability of hCDC14A or hCDC14B single knockout (KO) 
vertebrate cells (Mocciaro et al., 2010) indicates the possible functional redundancy 
of vertebrate phosphatases. It is noteworthy that most of the previously reported 
functions of hCDC14A/B were deduced upon siRNA depletion (often without a 
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rescue experiment) or strong over-expression that causes toxic effects. The extent of 
depletion, as well as the functional redundancy of the phosphatases, was not taken 
into consideration partly because of the inability of available antibodies to recognize 
endogenous hCDC14A and hCDC14B proteins (Guillamot et al., 2011; Mocciaro et 
al., 2010; Ovejero et al., 2012).  
CDC14 proteins display a conserved localization to the microtubule 
organizing centre such as the spindle pole body (SPB) in yeast and the human 
centrosome (Mailand et al., 2002; Pereira et al., 2002). CDC14 is also associated with 
the basal body during ciliogenesis (Ah-Fong and Judelson, 2011; Clément et al., 
2012). Recently, an autosomal recessive nonsense mutation in hCDC14A has been 
reported to cause severe to profound deafness due to defective transient kinocilia of 
developing cochlear hair cells and the persistent kinocilia of vestibular hair cells in 
the organ of Corti (Delmaghani et al., 2016; Imtiaz et al., 2018). Furthermore, shorter 
cilia have been reported in zebrafish upon cdc14a or cdc14b depletion with 
morpholinos (Clément et al., 2011, 2012).  However, it is still an open question 
whether CDC14A regulates primary cilia in human cells and how CDC14A 
promotes ciliogenesis on a molecular level. 
 
1.7 Connection between Cilia and cell cycle 
Cilia and flagella are microtubule-based membranous cell protrusions involved in 
motility and sensation. They are evolutionarily-conserved structures that differ from 
each other based on their length as well as number per cell. Vertebrate cilia are 
conventionally classified into motile cilia and sensory primary cilia (Takeda and 
Narita, 2012). Motile cilia and flagella are considered as highly comparable 
organelles due to their 9+2 axonemal configuration (a central pair of singlet 
microtubules surrounded by nine doublet microtubules) and intraflagellar transport 
(IFT) machinery (Satir and Christensen, 2007; Satir et al., 2008). Primary cilia are 
generally non-motile organelle with a 9+0 axonemal configuration and are involved 
in sensing and integrating external signals. Most cells (not all) have the capacity to 
form cilia whereas most cancer cells (not all) lack cilia (Keeling et al., 2016). 
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Assembly of primary cilia is tightly coordinated with the cell cycle phases. 
Generally, cilia assemble when cells become quiescent (G0) or differentiate. The 
primary cilia are disassembled through the signaling cascade that stimulates cells to 
re-enter the cell cycle. Upon the completion of mitosis, centrosomes become 
competent again to initiate primary cilia formation either in G0 or in early G1 phase 
(Figure 1.6) (Sánchez and Dynlacht, 2016). The structure of primary cilia can be 
divided into ciliary skeleton and ciliary membrane (Figure 1.7) (Hoerner and 
Stearns, 2013). The ciliary skeleton is composed of a basal body with nine 
microtubule triplets and an axoneme extension with nine microtubule doublets 
(Gluenz et al., 2010). The transition between microtubule triplet to doublet is termed 
as transition zone and is marked by Y-shaped bridges extending from microtubule 
doublets to the ciliary membrane (Aubusson-Fleury et al., 2012; Gluenz et al., 2010). 
Thus, the transition fibers serve as anchors for the basal body to the ciliary 
membrane. Ciliary rootlets provide a second level of anchorage by interconnecting 
the mother centriole (basal body) and daughter centriole (Broekhuis et al., 2014) with 
the nucleus (Figure 1.7). 
 
Figure 1.6: Linkage between cilium and cell cycle (Adopted from Sánchez and 
Dynlacht, 2016). 
Primary cilia assemble specifically in G0 or early G1 phase. Only the mother centriole 
with proteinaceous appendages can initiate ciliogenesis (assembly of cilia). Generally, 
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the cilia assembling role and the microtubule organizing spindle assembling role of 
centrosomes are mutually exclusive. So, the cilium assembled in G0 or early G1 phase 
must be disassembled to allow cells entering S phase and assemble spindles in M-
phase (Sánchez and Dynlacht, 2016). 
 
 
Figure 1.7: Structure of primary cilia (Adopted from Ke and Yang, 2014). 
Primary cilia are microtubule-based structures surrounded by ciliary membranes. 
Mother centriole, termed as basal body, primes ciliogenesis by the extension of 
microtubule structure. The transition zone is marked with Y-shaped bridges and 
positioned between basal body with microtubule triplets and axoneme with 
microtubule doublets. The basal body is connected to the daughter centriole through 
ciliary rootlet (Ke and Yang, 2014). 
 
Ciliogenesis is a complex process that involves precise spatial as well as 
temporal regulation of several intertwined cellular events like cell cycle progression, 
vesicular docking, and ciliary extension (Avasthi and Marshall, 2012). Assembly of 
primary cilium initiates through the conversion of mother centriole to basal body 
(Figure 1.8). Upon exit from the cell cycle, a guanine nucleotide exchange factor 
(GEF) called Rabin 8 is recruited to the pericentriolar recycling endosome and gets 
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activated by Rab11. Activated Rabin 8, in turn, activates Rab8a vesicles for their 
recruitment and docking to the distal appendages (distal appendage vesicles, DAV). 
Smaller distal appendage vesicles undergo EHD1-mediated fusion to form larger 
ciliary vesicles (CV). Further axoneme growth and microtubule extension depend on 
the acquisition of positive regulators (TTBK2, MARK4, IFT) as well as the removal of 
negative regulators (CP110, Trichoplein). Subsequently, the ciliary gate termed as 
transition zone (TZ) is assembled, and various IFT proteins help transport proteins 
through this gate (Sánchez and Dynlacht, 2016). 
 
 
Figure 1.8: Critical events in primary cilia assembly process (Adopted from 
Sánchez and Dynlacht, 2016). 
A series of highly orchestrated events causes the initiation and elongation of cilia 
termed as ciliogenesis or cilia assembly. The ciliogenesis process can be divided into 
four sequential events: (I) Conversion of mother centriole to basal body through 
acquisition of distal appendage; (II) formation of distal appendages vesicles (DAV) 
through docking of Rab8a vesicles (Yellow); (III) Ehd1-mediated fusion of DAV to 
form larger ciliary vesicles (CV); (IV) removal of negative regulators and concomitant 
acquisition of positive regulators ensuring axoneme growth and microtubule 
extension (Sánchez and Dynlacht, 2016). 
 
Cilium disassembly is triggered when the cell is committed to re-enter the cell 
cycle through stimulation by serum growth factors (Figure 1.9). In G1 phase, the 
concerted actions of two kinesin motor proteins (Kif2a and Kif24) and destabilization 
of acetylated tubulins are critical for cilia disassembly. The kinesins cause the 
inhibition of axoneme extension whereas tubulin de-acetylation leads to the 
disassembly of microtubule cytoskeleton (Sánchez and Dynlacht, 2016). Activation of 
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Aurora A kinase (AurA) by several different ways leads to phosphorylation 
mediated activation of histone deacetylase 6 (HDAC6) and tubulin de-acetylation 
(Plotnikova et al., 2012). HDAC6 was also reported to deacetylate cortactin and 
thereby enhancing actin polymerization by augmenting interaction between 
cortactin and filamentous actin (Ran et al., 2015). Thus, HDAC6 promotes cilium 
disassembly through stimulating actin polymerization. Trichoplein and Pitchfork 
(Pifo) are two additional molecules that lead to activation of AurA and cilium 
disassembly (Inoko et al., 2012; Kinzel et al., 2010; Sánchez and Dynlacht, 2016). 
 
 
Figure 1.9: Critical events mediating cilium disassembly (Adopted from Sánchez 
and Dynlacht, 2016). 
Upon mitogen stimulation, Plk1-mediated phosphorylation of Kif2a causes 
destabilization of acetylated tubulins in the ciliary axoneme. Activation of AurA 
through several signalling inputs activates HDAC6 and causes tubulin destabilization 
by deacetylation. A second depolymerizing kinesin is activated at a later time by 
Nek2 and thereby prevent reciliation throughout S/G2/M phases (Sánchez and 
Dynlacht, 2016). 
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1.8 Ciliopathies associated with defects in primary cilium signaling 
The roles of cilia in integrating a plethora of signalling pathways critical to 
vertebrate development and differentiation have placed this organelle in the frontier 
of current research (Ishikawa and Marshall, 2017). Loss or malfunction of cilia affects 
a wide range of human organ systems and causes diseases that have been termed as 
ciliopathies (Fry et al., 2014; Reiter and Leroux, 2017). Generally, the ciliopathies can 
be characterized as monogenic recessive disorders and the disease outcome is the 
combination of defective cilia structure and associated altered ciliary signalling 
(Figure 1.10).  
 
Figure 1.10: A schematic overview of the primary ciliary signaling and associated 
ciliopathies (Adopted from Fry et al., 2014). 
Cilia are receptor-enriched cell protrusions and several signalling pathways are 
regulated through cilia. Defective ciliary signalling affects almost all major organs and 
leads to ciliopathies such as MKS (Meckel-Gruber Syndrome); JBTS (Joubert 
Syndrome); BBS (Bardet-Biedl Syndrome); NPHP (nephronophthisis); OFD (Oral-
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Facial-Digital Syndrome); SLS (Senior-Løken Syndrome); AS (Alstrom Syndrome); 
SRPS (Short Rib-Polydactyly Syndrome); EVS (Ellis-van Creveld Syndrome) (Fry et 
al., 2014). 
 
1.9 Actin and ciliogenesis  
The actin cytoskeleton has been described to have significant regulatory input in 
ciliogenesis (Figure 1.11) (Malicki et al., 2017). In general, actin polymerization 
inhibits ciliogenesis whereas actin-severing factors, such as cofilin and gelsolin-
family proteins, boost cilia formation. The addition of low concentrations of the F-
actin depolymerizing drug cytochalasin D promotes cilia elongation partly by 
regulating vesicle trafficking and inhibiting cilia disassembly factors (Kim et al., 
2010, 2015). In addition, actin and the actin regulator drebrin (DBN1) mediate the 
release of vesicles, so-called ectosomes, from the tip of cilia (Nager et al., 2017). 
Recently, it was suggested that a branched, Arp2/3 organized actin network 
surrounds the centrosome and promotes transport of preciliary vesicles to the basal 
body via the action of the myosin-Va motor protein (Wu et al., 2018). Furthermore, 
CDK10/CycM protein kinase was proposed to negatively regulate ciliogenesis by 
inducing actin polymerization (Guen et al., 2016, 2018). 
The modulation of cilia function by actin cytoskeleton raises the question 
about regulators of the actin cytoskeleton, in particular kinases and phosphatases 
that control properties of cilia. In this respect, it is interesting that the proline 
directed phosphatase hCDC14A is associated with the actin cytoskeleton where it 
regulates cell migration and cell adhesion and in addition has functions in 
ciliogenesis (Chen et al., 2017, 2016; Clément et al., 2012; Delmaghani et al., 2016; 
Imtiaz et al., 2018). However, the molecular mechanism(s) governing the regulation 
of ciliogenesis by CDC14A remains elusive. 
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Figure 1.11: Regulation of ciliogenesis by actin cytoskeleton (Adopted from 
Malicki et al., 2017). 
(A) Several pathways regulate periciliary actin cytoskeleton. Posttranslational protein 
modifications such as deacetylation and phosphorylation of the actin regulator 
cortactin lead to actin polymerization and cilia disassembly. Cell cycle dependent 
signalling is also tightly linked to actin cytoskeleton remodelling that has an impact 
on ciliogenesis. (B) Actin affects ciliogenesis through multiple distinct mechanisms 
such as vesicle trafficking to the cilia base as well as localization of the ciliogenesis 
regulators to basal body (Malicki et al., 2017). 
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1.10 Aim of the thesis  
The focus of this study was to decipher the molecular mechanisms of human 
CDC14s functions by analysing knockout cellular models along with various protein 
tagging approaches. I have utilized zinc-finger nuclease (ZFN)-catalyzed double 
strand break followed by homologous recombination-mediated incorporation of 
premature stop codon and selection marker to target CDC14A (hCDC14A) and 
CDC14B (hCDC14B) loci in telomerase immortalized human retinal pigment 
epithelium (hTERT-RPE1) and HCT116 cells. Phenotypic analyses of the generated 
knockout (KO) cells were conducted to assign molecular functions to these proteins. 
RPE1 cells lacking hCDC14A functions displayed elongated cilia upon serum 
starvation. Global phosphoproteome, as well as proximity-based interaction 
proteomics approaches, were employed to identify substrates and thereby decode 
the molecular mechanism(s) of longer cilia in hCDC14A KO cells. 
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2 Results 
The following results and figures are parts of an already published article (Uddin et 
al., 2015) and a manuscript in preparation (Borhan Uddin, Patrick Partscht, Nan-
Peng Chen, Annett Neuner, Manuel Weiß, Robert Hardt, Aliakbar Jafar Pour, Bernd 
Heßling, Thomas Ruppert, Holger Lorenz, Gislene Pereira and Elmar Schiebel; The 
phosphatase hCDC14A and CDK5 kinase regulate cilia length through phospho-
regulation of the actin-binding protein drebrin). I have adopted the results from 
these manuscripts with subtle modifications. 
2.1 Generation of hCDC14 knockout cells 
2.1.1 Strategy for the generation of knockout cell lines 
Zinc finger nucleases (ZFN) specifically designed to target hCDC14A or hCDC14B 
loci were used to generate human cell lines devoid of these two phosphatase 
activities   (CompoZrTM ZFNs, Sigma Advanced Genetic Engineering Labs) (Chen 
et al., 2016; Uddin et al., 2015). hCDC14A and/or hCDC14B knockout cell lines were 
made using two human cell lines with stable genotype (hTERT-RPE-1 and HCT 116). 
Double strand break-induced homologous recombination strategy was employed to 
incorporate premature stop codon and selection markers (neomycin or puromycin) 
into the targeted exons of hCDC14A (9th exon) and hCDC14B (4th exon) (Figure 2.1). 
Southern blot analysis has confirmed the successful biallelic targeting of the 
hCDC14A and hCDC14B loci by NeoR or PuroR cassettes (Figure 2.2). 
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Figure 2.1: Strategy for ZFN-mediated generation of knockout cell lines (Adopted 
from Uddin et al., 2015).  
(A) Exon 9 of hCDC14A was targeted by zinc finger nuclease (ZFN). A donor template 
containing two homologous arms (HA), stop codon and neomycin selection cassette 
was used for their homologous recombination mediated insertion within the double 
strand break (DSB) site. Junction PCR with forward primer (blue arrow) in NeoR 
cassette and reverse primer (red arrow) in the genome outside homology arm 
confirmed successful targeting and insertion of the selection marker.  
(B) Exon 4 was targeted to knockout hCDC14B gene. Like donor template for 
hCDC14A, neomycin selection cassette was used to generate hCDC14B single 
knockout. Puromycin cassette was used when hCDC14B was knocked out on top of 
hCDC14A-/- cells (neomycin). Forward (blue) and reverse (red) primers used for the 
junction PCR are shown in the figure. 
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Figure 2.2: Southern blot hybridization to confirm biallelic targeting of hCDC14A 
and hCDC14B loci in RPE-1 cells (Adopted from Uddin et al., 2015). 
(A) Map for hCDC14A and hCDC14B genomic locus targeted by zinc finger nuclease 
(ZFN). The probes for Southern blot hybridization were designed in the right 
homologous arms (shown as green bar). In case of hCDC14A, digestion by Hind III 
would result in a 2.9 kb fragment for knockout cells instead of wild-type 1.2 kb band. 
For knocking out hCDC14B, neomycin or puromycin inserted donor templates were 
used. Puromycin construct (with an extra Hind III site) was used when hCDC14B 
knocking out was carried out on top of hCDC14A-/- cells (NeoR) (double knockout). 
On the other hand, neomycin construct was used during generation of single 
hCDC14B knockout. (B) Southern blot hybridization to confirm hCDC14A knockout 
(AKO) with a hCDC14A specific probe. The expected hCDC14A band sizes were 
observed for wild type (Wt, 1.2 kb), hCDC14A single (AKO) and hCDC14A hCDC14B 
double knockouts (DKO) (2.9 kb). (C) Southern blot hybridization to confirm 
hCDC14B knockout (BKO) with a hCDC14B specific probe. The DKO (see A, PuroR) 
and Wt cells have shown anticipated band sizes of 3.2 kb and 4.0 kb, respectively. For 
single hCDC14B knockouts (BKO), two extra bands above and below the expected 
band size of 5.7 kb (asterisks) was persistently observed in different clones. 
Nevertheless, absence of wild type bands (4.0 kb) in these knockouts confirmed the 
successful targeting of both alleles. 
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2.1.2 RT-PCR analysis confirming expression of wild type and in-frame exon-
skipped hCDC14A/ hCDC14B transcripts 
Sequencing of the hCDC14A and hCDC14B RT-PCR (reverse transcriptase 
polymerase chain reaction) products from wild type and selection marker knockins 
verified the presence of exon-skipped mature mRNA in the targeted hCDC14A and 
hCDC14B clones (Figure 2.3). The reading frames remain intact as the skipped exons 
in both the cases (9th exon for hCDC14A and 4th exon for hCDC14B) contained 
nucleotide numbers that could be divided by three. Hence, we assume the presence 
of truncated hCDC14A and hCDC14B proteins. The 9th exon of hCDC14A includes 
the active site cysteine and aspartate residues necessary for phosphatase activity 
(Bremmer et al., 2012; Gray et al., 2003; Hall et al., 2008), suggesting the inactivation 
of hCDC14A phosphatase from these cell lines (we termed these cells as 
hCDC14APD). Conversely, the catalytically important residues for hCDC14B are 
located in 9th exon, downstream to the targeted exon (Gray et al., 2003). Thus, in case 
of hCDC14B, the gene interference strategy most likely creates a small truncation of 
31 amino acids in the hCDC14B protein that might not affect phosphatase activity. 
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Figure 2.3: RT-PCR analysis to confirm expression of wild type and exon-skipped 
transcripts (Adopted from Uddin et al., 2015). 
Gel images for RT-PCR products of hCDC14A (A) and hCDC14B (B) transcripts from 
wild type (Wt) and knockout cells (KO). Maps show the locations of primers (black 
arrows) used for PCR reaction. The generated DNA bands were gel purified and 
sequenced. Sequences of alternating exon junctions are shown in the respective lower 
panels (exon 8 to 10 in case of hCDC14A and exon 3 to 5 for hCDC14B). In-frame exon 
skipping can be deduced from the amino acid sequences written above the codons. 
 
2.1.3 Exon-skipping phenomenon is independent of genome editing approach 
Our ZFN-mediated genome editing of hCDC14A and hCDC14B has clearly indicated 
the skipping of targeted exon from the final transcript. As a faster and more 
affordable alternative to ZFN, there is a recent surge in use of CRISPR-Cas9 system 
for genome editing. We have taken the advantage of CRISPR-Cas9 system to target 
hCDC14A locus with the same donor construct and guide RNA that targets the same 
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genomic hCDC14A DNA sequence as the ZFN. As the lengthy custom design of the 
ZFN was avoided, CRISPR-Cas9 strategy was clearly faster and more than 50-fold 
cost-efficient than the ZFN approach. As anticipated, we observed exon skipping in 
HCT 116 and RPE-1 cells in which hCDC14A was targeted by CRISPR-Cas9 (Figure 
2.4 and Figure 2.5). This further implies that the skipping event is associated with the 
degree of exon alteration not merely a random outcome of genome editing approach. 
 
 
Figure 2.4: Strategy for Cas9-mediated generation of hCDC14A knockout HCT 116 
cells (Adopted from Uddin et al., 2015). 
(A, B) Workflow for CRISPR-Cas9 medicated insertion of NeoR into exon 9 of 
hCDC14A. Guide RNAs (gRNAs) targeting the exon 9 of hCDC14A gene were 
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designed using the web tool (http://crispr.mit.edu/ (Hsu et al., 2013)). ‘Church 
gRNA insert’ containing the U6 promoter and gRNA scaffold (Mali et al., 2013) was 
first synthesized as gBlock and cloned into pJet. The intended gRNAs were then 
inserted through PCR mutagenesis using primers indicated by arrows (top of B). The 
same donor construct (bottom of B) as in case of ZFN-mediated genome editing was 
used to target the locus. (C) Junction PCR (as in Figure 2.1 A) with forward primer in 
NeoR cassette and reverse primer in the genome outside homology arms confirmed 
successful targeting and insertion of the selection marker. (D) RT-PCR of purified 
mRNA from Wt and different CRISPR-Cas9 targeted hCDC14A-KO clonal cells. 
Primers were as in Figure 2.3 A. Presence of both wild type and exon-skipped RNA 
indicated the targeting of single allele in clone 17. The other NeoR clones 7, 15, and 19 
contained bi-allelic targeting of the hCDC14A gene. (E) The generated DNA bands of 
the RT-PCR were gel purified and sequenced. Sequences of alternating exon junctions 
of hCDC14A are shown and in-frame exon skipping can be deduced from the amino 
acid sequences written above the codons. 
 
 
Figure 2.5: Strategy for Cas9-mediated generation of hCDC14A knockout RPE-1 
cells (Adopted from Uddin et al., 2015). 
(A) Workflow for the construction of RPE-1 hCDC14A-KO cell line. pCW-Cas9 
plasmid containing doxycycline (Dox) inducible spCas9 was lentivirally integrated 
into RPE-1 FRT/T-Rex cells. (B, C) Successful expression and nuclear localization of 
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Cas9 was confirmed by indirect-immunofluorescence (B) and immunoblotting (C). (D) 
Junction PCR with forward primer in NeoR cassette and reverse primer in the genome 
outside homology arm (as in Figure 2.1) confirmed successful targeting and insertion 
of the selection marker. Exon skipping was confirmed by RT-PCR (primers as in 
Figure 2.3). Presence of both wild type and exon-skipped RNA indicated the targeting 
of single allele in clones 1 and 20. 
 
2.1.4 Minimizing the degree of alteration salvages the exon skipping 
As a cause of exon skipping, we hypothesized that large insertion-mediated 
alteration of the targeted exon affects the pre-mRNA structure (Valentine, 1998). 
Hence, to avoid large-scale genome editing, we have taken two experimental 
strategies. First, genomic loci were targeted by the same ZFNs but with error-prone 
NHEJ, to have random smaller insertions or deletions (Figure 2.6 A). Secondly, the 
selection markers flanked by loxP sites were removed by Cre-recombinase to 
generate loci with 45 base pair insertions including stop codons immediately 
followed by the single loxP site (Figure 2.6 B). In both the cases, sequencing of 
genomic loci indicated the expected abruptions. Similarly, sequencing of the RT-PCR 
products confirmed the likewise modifications within the targeted exons without 
their skipping from the mature transcript (Figure 2.6 A, B). Semi-quantitative RT-
PCR using GAPDH as a control (Carbery et al., 2010) indicated that the exon-skipped 
hCDC14B mRNA level was less than half of the wild-type mRNA (Figure 2.6 C). 
Such decrease in mRNA level might be due to transcriptional control (altered 
synthesis) and/or post-transcriptional regulation (altered stability) of disrupted 
cellular transcripts. Because of the lack of anti-hCDC14B antibodies that detect the 
endogenous proteins (Guillamot et al., 2011; Mocciaro et al., 2010; Ovejero et al., 
2012), we were unable to confirm this mRNA decrease at the protein levels. Thus, by 
ZFN and CRISPR-Cas9 strategies we were able to generate hCDC14APD and/or 
hCDC14B-/- RPE-1 and HCT 116 cells. 
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Figure 2.6: Exon skipping can be abolished by minimizing the degree of alteration 
(Adopted from Uddin et al., 2015). 
(A) Exon 4 of hCDC14B was targeted by ZFN to introduce double strand break (DSB) 
and error-prone NHEJ for random insertion and deletion. In some of the targeted loci, 
small alterations in the exon (one to fifteen bases) were observed. ZFN cutting sites 
are written in blue font and base deletions or insertions are marked by red font colour. 
Sequencing of the RT-PCR products confirmed identical base pair changes without 
exon skipping (sequence not shown). (B) The selection cassette flanked by loxP sites 
was removed by Cre-recombinase from HCT 116 and RPE-1 hCDC14B-KO cells. RT-
PCR analysis confirmed the presence of stop codon (11 bp) followed by one loxP site 
(34 bp) within the targeted exon in both the cell lines. (C) Semi-quantitative RT-PCR 
indicated that the exon-skipped mRNA level of RPE-1 cells is less than half of the 
wild-type mRNA. 40 ng of total RNA was used and the input RNA level was 
confirmed by GAPDH amplification as mentioned by Carbery et al. (2010). The 
experiment was performed three times with similar outcome. One representative 
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experiment is shown. The numbers below the agarose gel summarizes the relative 
abundance of the mRNA from three different experiments. 
 
 
 
2.2 Phenotypic analysis of knockout cell lines 
2.2.1 hCDC14C is not expressed in RPE-1 and HCT 116 cells 
We have constructed RPE-1 and HCT 116 cells double deleted for hCDC14A and 
hCDC14B (hCDC14APD hCDC14B-/-). The puromycin or neomycin marker in exon 4 
of hCDC14B was removed by Cre recombination to prevent exon skipping. The 
question remained whether RPE-1 hCDC14APD hCDC14B-/- cells expressed hCDC14C. 
hCDC14C is a retrogene that is nearly identical to the cDNA of hCDC14B (Rosso et 
al., 2008). However, hCDC14C is different from hCDC14B at several nucleotide 
positions (Figure 2.7, red asterisks). Analysis of the hCDC14B and hCDC14C mRNA 
in RPE-1 Wt and RPE-1 hCDC14APD and/or hCDC14B-/- cells by RT-PCR and 
sequencing (mRNA was treated with DNaseI to remove chromosomal DNA) only 
identified bases characteristic for hCDC14B but not for hCDC14C (Figure 2.7, 
middle). Without DNaseI treatment, we detected the mixed-read containing 
hCDC14C signature derived from the chromosomal DNA and the hCDC14B 
signature from the cDNA (Figure 2.7, top). In genomic DNA only the hCDC14C 
fragment was amplified by PCR (Figure 2.7, bottom; retrogene, no introns) because 
of the large intron size in hCDC14B. Identical results were obtained with HCT 116 
Wt and HCT 116 hCDC14APD and/or hCDC14B-/- cells. Thus, hCDC14C is not 
expressed in RPE-1 Wt, RPE-1 hCDC14APD and/or hCDC14B-/-, HCT 116 Wt, HCT 
116 hCDC14APD and/or hCDC14B-/- cells. 
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Figure 2.7: hCDC14C is not expressed in RPE-1 and HCT 116 cells. 
Expression of hCDC14C in various cell lines was tested by RT-PCR and sequence 
analysis. The red stars mark the bases that are different between hCDC14B and 
hCDC14C. Upper lane: mix of chromosomal DNA and cDNA from DNase I untreated 
RNA. Middle: sequence analysis of the RT-PCR product from RPE-1 hCDC14APD and 
hCDC14B-/- (BAKO3) cells showed expression of only hCDC14B but not hCDC14C. 
Identical results were obtained for RPE-1 Wt cells. Bottom: PCR analysis of genomic 
DNA from RPE-1 cells identified only the chromosomal hCDC14C signature. 
 
 
2.2.2 Growth and cell cycle analysis of hCDC14APD and hCDC14B-/- cells 
MTT assay was used for an indirect measurement of cell growth. It is a colorimetric 
assay for evaluating cell metabolic activity, which in turn reflects the total number of 
cells. The MTT assay did not indicate an altered metabolic activity of RPE-1 Wt, 
hCDC14APD and/or hCDC14B-/- cells (Figure 2.8 A, B). Secondly, analysis of the cell 
cycle profile using FACS analysis showed no significant difference in the cell cycle 
phases between Wt, single, and double hCDC14A/B mutant cell lines (Figure 2.8 C). 
So, it can be convincingly stated that hCDC14A/hCDC14B are not essential for the cell 
cycle progression of RPE-1 and HCT 116 cells. 
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Figure 2.8: Analysis of hCDC14APD and/or hCDC14B-/- cell lines. 
(A, B) Growth analysis of RPE-1 Wt, hCDC14APD (AKO4, 6 and 7), hCDC14B-/- (BKO5 
and 10) and hCDC14APD hCDC14B-/- (BAKO3, 17 and 20) cell lines using the MTT 
assay (colorimetric assay for measuring cells’ metabolic activity). The small growth 
differences seen in B) were statistically insignificant. (C) Investigation of the 
distribution of cell cycle phases of RPE-1 Wt, AKO4, BKO10, and BAKO3 cell lines by 
FACS (propidium iodide) analysis.  
 
 
2.3 hCDC14A regulates cilia length 
2.3.1 hCDC14APD RPE-1 cells have longer cilia than Wt cells  
hCDC14A is a conserved phosphatase with suggested but unclear role in ciliogenesis 
(Ah-Fong and Judelson, 2011; Clément et al., 2012; Delmaghani et al., 2016). To 
understand the function of hCDC14A in cilia formation, we analysed serum starved 
RPE-1 hCDC14APD cells for cilia formation in comparison to Wt cells. hCDC14APD 
cells formed cilia as efficient as Wt cells independent of the cells’ confluency (Figure 
2.9 A, B). However, cilia of hCDC14APD cells were longer in comparison to those of 
Wt cells (Figure 2.9 A, C). siRNA mediated depletion of hCDC14A also caused the 
formation of elongated cilia (Figure 2.9 D). 
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Figure 2.9: Ablation of hCDC14A phosphatase activity in human RPE-1 cells leads 
to the elongation of primary cilia. 
(A) The cells were serum starved for 48 hours for inducing ciliogenesis prior to 
fixation. Cilia were stained with Arl13B while the basal bodies were marked with 
CEP250 (C-Nap1). Cilia from the magenta box marked area were enlarged for a clear 
view. (B, C) Percent of ciliated cells, as well as the length of cilia, was quantified from 
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A. hCDC14A phosphatase dead (hCDC14APD) cells show a similar percentage of cilia 
compared to wild type (Wt) cells. Cilia length was measured by a semi-automated 
ImageJ macro as described in methods section. (D) Elongated cilia phenotype was 
further confirmed by siRNA-mediated knockdown of hCDC14A. (E) The dynamics of 
ciliogenesis was determined by serum starving the Wt and hCDC14APD cells for 
different time-points (0, 4, 8, 24, 48 and 96 hours). The cilia from hCDC14APD cells 
continue to grow even after 48 hours of starvation whereas those from Wt cells reach 
optimum length within 12 to 24 hours. (F, G) In a time course experiment, the cilia 
disassembly kinetics was measured by first inducing the ciliation through 48 hours of 
serum starvation prior to incubation with serum containing media for different time 
points (0, 1, 4, 6, 24 hours). Measurement of cilia length indicated the comparable 
rates of cilia disassembly in RPE-1 Wt and hCDC14APD cells (**** P<0.0001). Sizes of 
the scale bars are indicated next to the designated images. 
 
Mutations can affect cilia length because of the impairment of cilia 
disassembly when cells re-enter the cell cycle upon growth factor addition (Maskey 
et al., 2015). To evaluate this possibility, we compared cilia formation and cilia 
disassembly of Wt and hCDC14APD cells. Elongation of cilia in response to serum 
starvation plateaued in Wt cells after 12 hours with an average cilium length of 2.8 
µm (Figure 2.9 E). In contrast, cilia continued to elongate in hCDC14APD cells over 96 
hours reaching a length of 4.6 µm. Cilia disassembly was even slightly faster in 
hCDC14APD cells in comparison to Wt cells (Figure 2.9 F, G). This suggests that it is 
cilia length control but not cilia formation or disassembly, which is defective in 
hCDC14APD cells. In addition, hCDC14PD/+ cells carrying only one Wt hCDC14A gene 
displayed an intermediate cilia length phenotype. Conversely, elongated cilia were 
not observed in RPE-1 cells lacking the hCDC14A paralogue hCDC14B (hCDC14B-/-) 
suggesting that the cilia phenotype is specific to hCDC14A (Figure 2.10). 
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Figure 2.10: Elongated cilia phenotype is specific to hCDC14APD cells. 
(A) One allele targeted hCDC14PD/+ cells displayed an intermediate cilia length 
phenotype compared to Wt and hCDC14PD/PD cells. (B) Elongated cilia were not 
observed in hCDC14B-/- RPE-1 cells suggesting that the cilia phenotype is specifically 
due to the lack of hCDC14A phosphatase activity (NS - not significant; ***P≤0.001; **** 
P≤0.0001). 
 
We next characterized the structure of hCDC14APD cilia in comparison to Wt 
to exclude structural defects. Electron microscopy did not show obvious defects in 
the basal body and axoneme organization of hCDC14APD cilia (Figure 2.11). In 
addition, the distal appendage protein CEP164, the subdistal appendage proteins 
CEP170, ODF2, and ninein, the transition zone protein NPHP1, the cilia shaft protein 
ARL13B, the transport protein IFT88, the linker proteins C-Nap1 and rootletin, and 
the PCM protein -tubulin were similarly associated with cilia in Wt and hCDC14APD 
cells (Figure 2.12). Intensity of these important basal body proteins were comparable 
in RPE-1 Wt and hCDC14APD cells (Figure 2.13). Thus, continuous elongation of cilia 
in hCDC14APD cells is causing the prolonged cilia phenotype without any noticeable 
structural defects. We next tested whether hCDC14A overexpression has the reverse 
phenotype of hCDC14A inactivation. Mild overexpression of hCDC14A but not the 
phosphatase dead version hCDC14AC278S from the inducible TetOn promoter 
drastically inhibited cilia formation (Figure 2.14 A). Taken together, hCDC14A 
regulates the assembly and length of cilia. 
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Figure 2.11: Electron micrograph of cilia from Wt and hCDC14APD cells. 
(A) Electron micrograph of cilia from 48 hours serum starved RPE-1 Wt and 
hCDC14APD cells. Basal body and the ciliary axoneme showed no gross structural 
defects in the longitudinal ciliary sections from hCDC14APD cells. (B) Similarly, 
the cross-sections of the basal body from Wt and hCDC14APD cells represented 
well organized triplet microtubule structure. Sizes of the scale bars are indicated 
next to the designated images (EM analysis was done in collaboration with 
Annett Neuner). 
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Figure 2.12: Cilia from hCDC14APD cells are structurally similar to those from Wt 
cells. 
Markers representing various basal body localizations showed no obvious localization 
defects for (A) pericentrin; (B, E and F) the distal appendage protein CEP164; (C, D 
and E) the subdistal appendage proteins (C) CEP170, (D) ODF2, and (E) Ninein; (C 
and G) the proximal end protein C-Nap1; (F) the transition zone protein NPHP1 and 
(G) the ciliary rootlet component rootletin (Scale Bars 1 µM). 
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Figure 2.13: Basal body protein intensities and interphase centrosomal distance of 
hCDC14APD cells are comparable to Wt cells. 
(A-G) Fluorescent intensity of the markers representing various basal body 
localizations were measured using an ImageJ macro described in method section. In 
brief, the fluorescent intensities within a 4.5-µm-radius circle surrounding the basal 
body was measured after background subtraction. 
(H-I) Interphase centrosomal distance (from unstarved cycling cells) were measured 
in Wt and hCDC14APD cells (clone 4, 6, 7) by manually measuring the linear distance 
between two centrosomes marked with Tubulin and PCNT. 
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2.3.2 hCDC14A localizes to the basal body and the actin cytoskeleton of ciliated 
cells  
CDC14A localizes to the axoneme of transient kinocilia of developing cochlear hair 
cells and the persistent kinocilia of vestibular hair cells (Imtiaz et al., 2018). The 
localization of hCDC14A in cells with a primary cilium is, however, unclear. 
Endogenous hCDC14A was detected in the basal body of serum-starved ciliated 
RPE-1 cells using an established anti-hCDC14A antibody (Chen et al., 2016) (Figure 
2.15). Similar localization was observed in RPE-1 cells stably expressing hCDC14A-
GFP and the phosphatase dead version hCDC14AC278S-GFP under TetON promoter 
control (Figure 2.14 D-G). However, we noticed that hCDC14A-GFP expression 
reduced the number of RPE-1 cells with cilia from 70% to 20%. This reduction was 
not observed when the phosphatase dead hCDC14AC278S-GFP was expressed (Figure 
2.14 A). In addition, hCDC14A-GFP was detected along actin cables in ciliated cells 
(Figure 2.14 B and C) as reported for interphase cycling cells (Chen et al., 2016).  
For a more detailed analysis of the hCDC14A localization, we focused on 
hCDC14AC278S-GFP that did not affect ciliogenesis. A closer inspection of the basal 
body indicated the presence of two pools of hCDC14AC278S-GFP. The most intense 
fraction was enriched at the proximal end of the basal body that contains the linker 
protein C-Nap1 (encoded by CEP250) (Fry et al., 1998; Mayor et al., 2000) (Figure 
2.14 D and E). Confirming this localization, hCDC14A-GFP was lost from the basal 
body’s proximal end in CEP250-/- RPE-1 cells (Figure 2.14 F and G) (Panic et al., 
2015). The second pool, relatively weak in intensity, was at the distal end of the basal 
body that organizes the cilium (Figure 2.14 D). hCDC14A localized underneath the 
distal appendage marker CEP164 and overlapped in its localization with the 
subdistal appendage protein ODF2 (Ishikawa et al., 2005; Mazo et al., 2016). The 
cartoon in Figure 2.14 E summarizes hCDC14A localization at basal bodies. Thus, in 
ciliated cells hCDC14A associates with the actin cytoskeleton and basal body. 
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Figure 2.14: hCDC14A negatively regulates ciliogenesis and is localized to actin as 
well as to the basal body. 
 (A) hCDC14A-GFP and hCDC14AC278S-GFP under control of the TetON promoter 
were stably integrated into RPE-1 cells. hCDC14A-GFP and hCDC14AC278S-GFP 
localized to the basal body. In addition, expression of hCDC14A-GFP but not the 
phosphatase dead hCDC14AC278S-GFP mutant inhibited cilia formation. Expression of 
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hCDC14A-GFP and hCDC14AC278S-GFP were validated by immunoblot analysis.  (B) 
TetON-hCDC14A-GFP RPE-1 cells were serum starved for 48 hours prior to fixation 
and immunofluorescence microscopy. hCDC14A-GFP colocalizes with Phalloidin 555 
conjugated dye that marks F-actin fibres. (C) Line scan inside the magenta-coloured 
box showed in B. The scanned areas were enlarged and displayed below the 
corresponding images in B.  (D) Sub-centrosomal localization of hCDC14AC278S-GFP 
was determined by the correlative positioning of GFP signal with the proteins Arl13B 
and IFT88 (cilia), C-Nap1 (proximal end), CEP164 (distal appendage) and ODF2 
(subdistal appendage). (E) Cartoon of cilia indicating the localization of hCDC14A. (F, 
G) CEP250-/- cells showed only the sub-distal and centriolar localizations of 
hCDC14AC278S-GFP indicating the CEP250 dependence of hCDC14A proximal end 
localization. Sizes of the scale bars are indicated next to the designated images. 
 
 
Figure 2.15:  Endogenous hCDC14A as well as BirA tagged hCDC14A are localized 
to basal body. 
(A) Endogenous hCDC14A could be detected in the basal body of RPE-1 Wt cells 
under ciliogenic condition. (B) hCDC14A-BirA or hCDC14AC278S-BirA could also be 
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detected in the basal body, whereas BirA showed a diffused cellular signal without 
any basal body enrichment. Sizes of the scale bars are indicated next to the designated 
images. 
 
 
2.3.3 hCDC14A dephosphorylates actin associated proteins during ciliogenesis 
We have applied global phosphoproteome along with proximity-based interaction 
proteomics approaches under conditions that favor ciliation to identify substrates 
and proximity neighbours for hCDC14A. First, stable isotope labelling with amino 
acids in cell culture (SILAC) (Ong et al., 2002) allowed us to identify proteins that 
became dephosphorylated upon TetON-induced expression of hCDC14A-GFP by 
doxycycline (Dox) under cilia promoting conditions (Figure 2.16 A-D). Comparison 
of the phospho-proteomes of non-induced and induced hCDC14A-GFP expressing 
cells by mass spectrometric analysis identified actin-associated proteins such as 
DBN1, synaptopodin (SYNPO), and the LIM domain and actin binding 1 (LIMA1). 
In addition, we identified the microtubule-associated protein MAP4 that functions in 
cilia length control (Ghossoub et al., 2013) (Figure 2.16 B and C). Interestingly, most 
of the phosphosites that were dephosphorylated by hCDC14A followed the pSP 
consensus of CDC14 phosphatases (Figure 2.16 D) (Chen et al., 2017; Eissler et al., 
2014; Visintin et al., 1998). However, compared to human cycling cells, in which 
hCDC14A preferentially dephosphorylates pSPxK/R sites (Chen et al., 2017), the 
preference for positively charged amino acids at position pS+3 was less pronounced 
under serum starvation (Figure 2.16 D). The proximity BioID analysis (Roux et al., 
2012) was performed with both hCDC14A Wt and the phosphatase dead 
hCDC14AC278S N-terminally tagged to the promiscuous biotin protein ligase (BirA). 
The BirA fused hCDC14A also showed actin as well as basal body localization 
(Figure 2.15). During ciliogenesis, hCDC14A and hCDC14AC278S localized close to 
actin-associated proteins DBN1 and LIMA1 which is consistent with the phospho-
proteome analysis (Figure 2.16 E and F). 
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Figure 2.16: Identification of substrates and proximity neighbors of hCDC14A 
during ciliogenesis. 
(A) Experimental scheme for hCDC14A-GFP overexpression combined with 
phosphoproteome (SILAC) analysis. (B) Molecular network of the hypo-
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phosphorylated proteins in hCDC14A-GFP overexpressed cells. Gene network was 
constructed in Cytoscape using the function prediction GeneMANIA app. Physical 
interactions are denoted by solid lines (edges) whereas the shared protein domain 
interactions are represented by broken lines. The extent of interactions (degree) is 
indicated by the Node size. The query proteins are marked with thick borders and the 
actin-related proteins are marked with Magenta-coloured nodes. (C) Gene Ontology 
(GO) analysis of the proteins that are two-fold hypo-phosphorylated in the heavy 
(hCDC14A overexpressed) samples. Values inside the parentheses indicate P values. 
(D) Substrate motif identified by analysing the sequences of hypo-phosphorylated 
peptides in Perseus. (E) Molecular network of the neighbours of hCDC14A identified 
by Proximity-dependent biotin identification (BioID) during ciliogenesis. Gene 
network was constructed in Cytoscape as described in B by considering the physical 
interactions only. (F) Gene Ontology (GO) analysis of the proteins from which at least 
five peptides were two-fold enriched in the hCDC14A-BirA and hCDC14A-CS-BirA 
samples compared to BirA control. 
 
In a secondary screen, we tested proteins that were identified by the phospho-
proteome and BioID analyses for their impact on cilia length control. Proteins were 
depleted by siRNA during ciliogenesis of RPE-1 Wt and hCDC14APD cells (Figure 
2.17). Cilia length was subsequently measured by indirect immunofluorescence 
microscopy. Depletion of several proteins such as the subdistal appendage protein 
CEP170 had no impact on the cilia length in Wt and hCDC14APD cells (Figure 2.17). 
DBN1, MTCL1, and UBAP2L depletion significantly increased the length of cilia in 
Wt cells without affecting those in hCDC14APD cells. On the contrary, siRNA of 
KANK2, MAP4, PDLIM7, and RPS2 reduced the length of hCDC14APD cilia without 
having an impact on Wt cilia. In summary, hCDC14A phosphoproteome and BioID 
analyses identified putative CDC14A substrates that affect cilia length. 
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Figure 2.17: siRNA screen to find proteins with critical function in cilia length 
control. 
(A) Experimental scheme for siRNA screen to find hCDC14A substrate(s) essential for 
cilia length control. (B, C, D and E) Proteins were depleted by siRNA during 
ciliogenesis of RPE-1 wild type and hCDC14APD cells. Cilia length was subsequently 
measured by indirect immunofluorescence microscopy. (The experiment was 
repeated twice, and 70 to 150 cilia were measured for each experiment; * P≤ 0.05; ** P≤ 
0.01; *** P≤ 0.001; **** P≤ 0.0001). 
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2.3.4 hCDC14A regulates phosphorylation of DBN1 
We focused the further analysis on DBN1, which is a known phosphoprotein with 
functions in ciliogenesis (Nager et al., 2017; Worth et al., 2013). Mass spec analysis 
indicated that serine residue 142 of DBN1 became dephosphorylated by hCDC14A 
in RPE-1 cells during ciliogenesis (Figure 2.18). In cycling cells, this “SP” site is 
phosphorylated by the proline directed kinase CDK5 (Tanabe et al., 2014; Worth et 
al., 2013). Analysis of the phosphorylation status of S142 of DBN1 with a phospho-
specific antibody confirmed dephosphorylation of this site by Tet induced 
hCDC14A-GFP but not by the inactive hCDC14AC278S-GFP or GFP (Figure 2.18 A and 
B). In addition, S142 of DBN1 was hyperphosphorylated in hCDC14APD RPE-1 cell 
lines during ciliogenesis (clone 4, clone 6, and clone 7) compared to the Wt control 
(Figure 2.18 C). The identity of the pS142 DBN1 and DBN1 bands was confirmed by 
their reduction in response to DBN1 siRNA (Figure 2.18 C). Of note, 
phosphorylation of pS142 of DBN1 was reduced during ciliogenesis relative to 
cycling cells (Figure 2.22 A). This suggests that DBN1pS142 is a substrate of hCDC14A 
during ciliogenesis. To confirm direct dephosphorylation of DBN1 pS142 by 
hCDC14A, we incubated immuno-precipitated, phospho DBN1 with recombinant 
and purified hCDC14A. pS412 was efficiently dephosphorylated by recombinant, 
purified hCDC14A (Figure 2.18 D) indicating that hCDC14A directly 
dephosphorylates DBN1. 
 
 Results 
45 
 
 
Figure 2.18: The phosphoprotein DBN1 is a substrate for hCDC14A. 
(A, B) hCDC14A, not the inactive hCDC14AC278S, dephosphorylates the serine residue 
142 of DBN1 in vivo. RPE-1 cells expressing GFP, hCDC14A-GFP, and hCDC14AC278S-
GFP under TetON promoter were serum starved in presence or absence of Dox for 48 
hours prior to fixation for immunofluorescence (A) or lysing for immunoblot analysis 
(B). (B) The DBN1pS142/DBN1 ratio was densitometrically measured from the Dox 
treated samples and represented in the graph next to the immunoblot. (C) S142 of 
DBN1 was hyper-phosphorylated in hCDC14APD clones during ciliogenesis compared 
to the wild type control. The specificity of the DBN1pS142 antibody was validated by 
siRNA mediated knock-down of DBN1 in both hCDC14APD cells and GFP/hCDC14A-
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GFP/hCDC14AC278S-GFP stable cells. (D) In vitro dephosphorylation of DBN1 by 
purified hCDC14A enzyme. DBN1-GFP was transfected into HEK293T cells and 
immunoprecipitated with GFP binder after 48 hours of expression. The 
immunoprecipitated phospho-DBN1 was then incubated with hCDC14A to 
dephosphorylate in vitro. 
 
 
2.3.5 Phosphoregulation of DBN1 by hCDC14A contributes to cilia length 
control 
To confirm the function of DBN1 in cilia length regulation, we constructed 
independent DBN1 RPE-1 knockout cell lines using CRISPR/Cas9 technology 
(Figure 2.19 A). Three independent gRNAs targeting different exons of DBN1 were 
used to construct DBN1 KO cells (Figure 2.19 A). Analysis of the DNA sequences 
from several clonal cell lines confirmed the disrupting mutations in the DBN1 gene 
(Figure 2.19 B). As expected from gene disruption, DBN1 was no longer detected in 
DBN1 KO cell lines by immunoblotting with polyclonal antibodies (Figure 2.19 C). 
One clone of each gRNA (1.16, 2.18 and 3.3) was used for further ciliogenesis 
experiment and found to assemble longer cilia than Wt cells (Figure 2.19 D). Clone 
2.19 did not affect cilia length as this cell line did not carry a mutation in DBN1 and 
DBN1 protein was detected by immunoblotting (Figure 2.19 C). This data further 
confirms the role of DBN1 in cilia length regulation. 
 To test the impact of S142 phosphosite in DBN1 on cilia length control, we 
expressed DBN1 versions of Wt, phospho-inhibitory (S142A) and phospho-mimetic 
(S142D) in DBN1 KO and Wt RPE-1 cells under the control of TetON promoter. 
Expression of DBN1 in RPE-1 Wt cells increases cilia length (Figure 2.19 E). Because 
of this overexpression effect, we did not observe rescue of the cilia length phenotype 
by TetON-DBN1 in DBN1 KO cells (Figure 2.19 F). Interestingly, however, the non-
phosphorylated, DBN1S142A (Worth et al., 2013) significantly reduced cilia length in 
comparison to Wt or phospho-mimetic (S142D) DBN1 (Figure 2.19 F). Similar cilia 
length in both Wt and phospho-mimetic DBN1S142D has lead us to speculate that the 
overexpressed DBN1 might be phosphorylated inside the cells leading to the 
inactivation of the non-phosphorylated active DBN1. Indeed, immunoblotting of the 
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cell lysate with phospho-specific antibody confirmed that in TetON-DBN1 cells, 
DBN1 S142 phosphorylation was strongly elevated in comparison to the control 
without Dox (Figure 2.19 G). No DBN1pS142 signal was observed in cells expressing 
the S142A and S142D versions of DBN1, confirming the specificity of the DBN1pS142 
antibodies (Figure 2.19 G). Thus phospho-regulation of DBN1 is a mechanism that 
contributes to cilia length control. 
 
2.3.6 The kinase CDK5 and hCDC14A phosphatase counteract phosphorylation 
of DBN1 during ciliogenesis 
CDK5 is a proline directed kinase that in serum starved cells induces degradation of 
‘nuclear distribution protein nudE’ homolog 1 (NDE1) that promotes cilia 
disassembly upon re-entry of RPE-1 cells into the division cycle (Maskey et al., 2015). 
Hence, cells depleted of CDK5 have shorter cilia (Figure 2.19 H). We first asked 
whether CDK5 counteracts hCDC14A during ciliogenesis. Restoration of cilia length 
in hCDC14APD cells to Wt by CDK5 depletion supports this model (Figure 2.19 H). 
However, this length regulation of cilia by hCDC14A/CDK5 was not on the level of 
NDE1 since protein levels of NDE1 in ciliated hCDC14APD and Wt cells were similar 
(Figure 2.22 B). We next considered the possibility that S142 of DBN1 is also 
phosphorylated by CDK5 in RPE-1 cells during ciliogenesis (Tanabe et al., 2014; 
Worth et al., 2013). Indeed, depletion of CDK5 in hCDC14APD cells strongly reduced 
DBN1pS142 phosphorylation (Figure 2.19 I). To test this further, we expressed S142D 
phospho-mimetic version of DBN1S142D in hCDC14APD RPE-1 cells and subsequently 
depleted CDK5 by siRNA. Cilia length reduction by CDK5 depletion in hCDC14APD 
RPE-1 cells was completely inhibited by the expression of DBN1S142D (Figure 2.19 J). 
Thus, opposing phospho-regulation of DBN1 by CDK5 and hCDC14A affects cilia 
length. 
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Figure 2.19: Phospho-regulation of DBN1 is critical for cilia length control. 
(A) Schematic representation of different domains of drebrin (adapted from Shirao et 
al., 2017) (here ADF-H: ADF homology domain, AB1: Actin-binding region 1, AB2: 
Actin-binding region 2, P: Proline-rich region). The numbers represent the amino acid 
 Results 
49 
 
positions of the denoted domains. Three independent gRNAs targeting three different 
exons (3,5,7) of DBN1 were used to generate DBN1 KO cells. (B) Successful targeting 
of the locus of interest was confirmed by sequencing the PCR amplicons surrounding 
the locus. For example, in clone 3.3, there was a single base insertion in both alleles 
(T/G) to cause disruption of protein expression through introduction of a premature 
stop codon. (C) The absence of DBN1 protein in the targeted clones was further 
verified by immunoblotting of the whole cell lysate. GAPDH is used as loading 
control. (D) One targeted clone from each gRNA (1.16, 2.18, 3.3) including the 
nontargeted clone 2.19 and Wt control were serum starved for 48 hours to induce 
ciliogenesis and measure cilia length. The cilia from DBN1 KO cells were significantly 
longer than those from Wt or non-targeted controls. (E) Overexpression of DBN1-GFP 
in RPE-1 Wt cells caused the elongation of primary cilia. (F) The phospho-inhibitory 
(S142A) version of DBN1 rescued the elongated cilia of DBN1 KO cells. (G) The 
overexpressed Wt DBN1 was hyper-phosphorylated in cells. The pS142 antibody did 
not detect the overexpressed DBN1S142A or DBN1S142D. (H) Depletion of CDK5, the 
kinase that phosphorylates drebrin S142 (Worth et al., 2013), decreased the cilia length 
in Wt cells as well as rescued the elongated cilia of hCDC14APD cells. (I) Immunoblot 
analysis of (H) confirming the successful depletion of CDK5. The decrease in 
DBN1pS142 intensity was associated with CDK5 depletion. (J) CDK5 mediated cilia 
length decrease can be completely blocked by expression of the phospho-mimetic 
DBN1S142D in hCDC14APD cells. (ns = not significant; * P≤ 0.05; ** P≤ 0.01; *** P≤ 0.001; 
**** P≤ 0.0001). 
 
2.3.7 hCDC14APD cells show enhanced recycling endosome as well as elevated 
docking of ciliary vesicles to the basal body 
How does phospho-regulation of DBN1 control cilia length? Previously DBN1 was 
described as a member of an actin network that is involved in ectocytosis of ciliary 
vesicles from the cilia tip of inner medullar collecting duct (IMCD3) kidney cells that 
have an exposed primary cilium (Nager et al., 2017). In contrast to IMCD3 cells, 
DBN1 was not associated with any part of the cilium of RPE-1 cells that assemble 
cilia via the intracellular pathway (Figure 2.22 C) (Mazo et al., 2016). However, 
partial actin-DBN1 colocalization could be confirmed in RPE-1 cells (Figure 2.22 D). 
Continuous growth of cilia under serum starvation condition (Figure 2.9) raises the 
possibility that a feedback mechanism restricting cilia length in Wt cells is failing in 
hCDC14APD cells. Control of endocytic recycling to the pericentrosomal preciliary 
compartment (PPC) as well as the ciliary vesicle transport from the Golgi to the basal 
body may be such mechanisms (Joo et al., 2013; Kim et al., 2010; Ye et al., 2014). 
Interestingly, DBN1 KO HEK293 cells were reported to display enhanced 
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endocytosis of dynamin-dependent cargo (Li et al., 2017). Consequently, we first 
tested the uptake of transferrin as a marker for endocytic recycling during 
ciliogenesis. Indeed, uptake of transferrin was enhanced in hCDC14APD cells 
compared to Wt cells (Figure 2.20 A and B). Furthermore, elevated Smoothened 
(SMO) positive cilia in hCDC14APD cells indicated the enhanced ciliary vesicle 
docking during ciliogenesis (Figure 2.20 C and D). This elevated Smo signal in 
hCDC14APD cells also lead to an increase in ratio of Gli3 – full length/Gli3 – 
repressor form, which indicated that the Sonic Hedgehog signalling was active in 
these cells (Figure 2.21 C and D). The Hedgehog (Hh) signaling pathway plays 
pivotal roles in the regulation of embryonic development as well as of the 
proliferation and differentiation of stem cells. Accumulation of the signalling protein 
Smoothened (Smo), a 7-pass transmembrane (7TM) protein, in the membrane of 
primary cilia is a prerequisite for the activation of Hh signalling cascade. In the 
absence of ligands, the Hh receptor Patched-1 (Ptch) localizes in and around the 
cilium and inhibits the accumulation of Smo (Milenkovic et al., 2015). However, the 
cilia length of RPE-1 Wt and hCDC14APD cells could not be altered by inducing 
(SAG) or inhibiting (cyclopamine) Hedgehog signalling (Figure 2.21 A and B). 
Low dose of actin-depolymerizing drug cytochalasin D was reported to 
promote ciliogenesis by stabilizing the Arp2-associated pericentrosomal actin 
network (Wu et al., 2018). Similarly, we observed enhanced Arp2 as well as 
phalloidin intensity surrounding the 1 µm radius of the basal body in hCDC14APD 
cells (Figure 2.20 E-G). These data denote that hCDC14APD cells have a distinct local 
actin reorganization surrounding the basal body, which in turn contributes to cilia 
elongation. The involvement of actin modulation in cilia length control also come 
from the observation that the ciliogenesis inhibitory effect of hCDC14A over-
expression could be reverted by the treatment of low dose of cytochalasin D (Figure 
2.22 E).  
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Figure 2.20: hCDC14APD cells show enhanced recycling endosome as well as 
elevated docking of ciliary vesicles to the basal body. 
(A, B) hCDC14APD cells take up significantly higher transferrin that marks recycling 
endosomes. The fluorescence intensities of transferrin within a 2-µm-radius circle 
surrounding the CEP164 signal were quantified and presented in B. An ImageJ macro 
was used to measure the intensity as described in method sections. (C, D) Mouse 
smoothened C-terminally tagged to GFP was lentivirally integrated into RPE-1 Wt 
and hCDC14APD clones under TetON promoter. Cells were starved along with Dox 
treatment for 48 hours and the percentage of cilia that contain Smo-GFP signal was 
quantified. All the hCDC14APD clones contained a higher percentage of Smo-GFP 
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positive cilia compared to Wt control. (E, F, G) Sub-centrosomal (1-µm-radius) 
branched actin level was measured by quantifying the intensity of Arp2 and F-actin in 
Wt and hCDC14APD cells. hCDC14APD cells contain significantly higher branched actin 
in the pericentrosomal area (1-µm-radius) compared to Wt cells. The blue boxed 
region are enlarged and represented below the respective channels of both Wt and 
hCDC14APD cells.  
 
 
Figure 2.21: Modulation of Hedgehog signalling does not affect cilia length.  
(A) RPE-1 Wt and hCDC14APD cells were treated with vehicle control or Hedgehog 
signal inducing chemical SAG (Smoothened agonist, 0.4 µM). Cells were serum 
starved for 24 hours prior to SAG treatment along with starvation for 24 hours and 
fixation for immunofluorescence. (B) The Hedgehog inhibitor cyclopamine was also 
treated (10 µM) with similar experimental scheme before fixation and 
immunofluorescence microscopy to measure cilia length. (C) The whole cell lysates 
from RPE-1 Wt and hCDC14APD cells under ciliogenic condition were analysed for 
immunoblot detection of Gli3. (D) The ratio Gli3-FL (190KDa)/ Gli3-R (83KDa) was 
densitometrically determined. 
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Figure 2.22: DBN1 is dephosphorylated during ciliogenesis. 
(A) DBN1pS142 level was decreased over time during ciliogenesis. (B) RPE-1 Wt and 
hCDC14APD cells showed comparable fluctuation of NDE-1 during ciliation and cilia 
disassembly processes, i.e., the level is decreased upon serum starvation and again 
elevates gradually upon serum addition. (C) DBN1-GFP could not be detected in cilia. 
(D) Drebrin and F-actin co-localized in RPE-1 cells during ciliogenesis (scale bar 5 
µM). (E) The ciliogenesis suppressing effect of hCDC14A-GFP overexpression could be 
reversed by treating the cells with actin depolymerizing drug cytochalasin D (200 nM 
for 16hr in serum- free medium, n≥ 200). 
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3 Discussion 
3.1 Genome editing through large insertion leads to the skipping of 
targeted exon 
Genome editing is a robust experimental paradigm to assign cellular function(s) to a 
molecule. Simplicity of genome editing through engineered nucleases has recently 
allured the scientific community to generate knockout cellular models. Highly 
efficient genome editing can be achieved through targeting an endonuclease to 
specific locus of interest. Engineered zinc-finger nuclease (ZFN) and CRISPR-
associated protein-9 nuclease (Cas9) offer such an elegant approach for genome 
editing in vertebrate cells. In this study, we have utilized ZFN and Cas9-catalyzed 
double strand break followed by homologous recombination-mediated 
incorporation of premature stop codon and selection marker to target human cell 
division cycle 14A (hCDC14A) and cell division cycle 14B (hCDC14B) genes. 
Targeting of the hCDC14A and hCDC14B loci in telomerase immortalized human 
retinal pigment epithelium (hTERT-RPE-1) and human colon cancer (HCT 116) cells 
were confirmed by Southern blot hybridization. Nevertheless, DNA sequence 
analysis of reverse transcription polymerase chain reaction (RT-PCR) products 
confirmed that in all the single/double allele ablations, the targeted exon was 
spliced out. The phenomenon of exon skipping was independent of the genome 
editing approaches exploited, Cas9 or ZFN. Because the exons had a nucleotide 
number that could be divided by 3, the reading frame of the exon deletion was 
maintained. This indicates an exon-skipping event possibly due to the insertion of 
large DNA fragments (1.7 to 2.5 Kb) within the targeted exons. As a proof-of-
principle, we have used gene disruption followed by non-homologous end joining 
(NHEJ) approach. Small alterations in the exon (one to fifteen bases) were 
transcribed to mRNA without exon skipping. Furthermore, loxP site-mediated 
removal of selection markers left a 45 bp scar within the targeted exon that can be 
traced in mRNA without exon skipping.  
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Thus, insertion of a large DNA fragment into an exon by genome editing has 
the potential to annihilate secondary pre-mRNA structure and impede cellular 
mRNA processing leading to exon skipping. Hence, more cautious approach needs 
to be taken while designing target sites in such that the possible skipping of targeted 
exon causes a frame-shift mediated incorporation of pre-mature stop codon. An 
alternative strategy could be the introduction of double strand break in an intronic 
sequence to incorporate homologous recombination mediated subtle changes in the 
adjacent exon. These exon modifications could be introduced in the donor along 
with the selection marker. Of note, such skipping mechanisms can be useful to 
engineer proteins with small deletions or for the analysis of acute knockouts in 
response to Cre induced selection marker removal. 
 
3.2 hCDC14A and hCDC14B double knockout cells show no obvious 
growth defects 
Expression analysis of Wt as well as hCDC14A and hCDC14B double knockout cells 
showed that hCDC14C was not expressed in RPE-1 and HCT 116 cells. This ruled out 
the possible functional complementation of hCDC14A and hCDC14B loss by 
hCDC14C. The generated knockout cells were also subjected to general growth 
analysis by MTT and cell cycle distribution analysis by FACS. Absence of any 
obvious growth defects in the knockout cells have indicated that hCDC14A and 
hCDC14B are dispensable for cell cycle progression in RPE-1 and HCT 116 cells. 
Thus, the mitotic exit function of ScCDC14 is not conserved in higher eukaryotes like 
human and is considered to be taken over by PP1 and PP2A (De Wulf et al., 2009).  
 
3.3 The phosphatase hCDC14A regulates cilia length  
CDC14 phosphatases regulate ciliogenesis in several organisms including Zebrafish, 
mouse and human cells. CDC14A mutations in humans and mice that affect the 
activity of the phosphatase impair formation of the transient kinocilia of developing 
Discussion 
56 
 
cochlear hair cells and the persistent kinocilia of vestibular hair cells in the organ of 
Corti (Imtiaz et al., 2018). Kinocilia in the organ of Corti are motile 9+2 cilia with a 
special function in the organization of actin-based stereocilia. Data presented in this 
study now indicate that hCDC14A plays a role in cilia length control of 9+0, non-
motile primary cilia. However, in contrast to Zebrafish that showed shorter cilia in 
response to CDC14A or CDC14B depletion (Clément et al., 2011, 2012), expression of 
a phosphatase dead version or hCDC14A depletion resulted in longer cilia. This 
length phenotype was specific to hCDC14A and was not observed in cells lacking 
the paralogue hCDC14B. Presently, it is unclear why inactivation of CDC14A in 
Zebrafish and human cells impact cilia length in opposite ways. However, variations 
in cilia phenotypes between organisms upon inactivation of orthologous have been 
reported before (Hamel et al., 2017). 
Phospho-proteome and BioID analysis revealed several hCDC14A substrates 
during ciliogenesis, which were mostly dephosphorylated on pSP sites. This is the 
signature of CDC14A phosphatases from yeast to human cells (Chen et al., 2017; 
Eissler et al., 2014). However, in contrast to cycling cells, in which hCDC14A prefers 
pSPxK/R sites (Chen et al., 2017) the preference for the positively charged amino 
acid in +3 position was less pronounced under serum starvation conditions that 
promoted cilia formation. The reason for this difference in substrate specificity may 
be the regulation of hCDC14A during ciliogenesis. Here we focused our analysis on 
the actin bundling protein DBN1 because of its reported role in ciliogenesis (Nager et 
al., 2017). Analysis of DBN1pS142 with a phospho-specific antibody confirmed that 
DBN1 was hyper-phosphorylated in hCDC14PD RPE-1 cells in comparison to Wt 
cells, while overexpression of hCDC14A reduced pS142 phosphorylation. Purified, 
recombinant hCDC14A dephosphorylated DBN1 at S142 indicating direct regulation 
by hCDC14A. Our data suggest that S142 of DBN1 is phosphorylated by the proline 
directed kinase CDK5 during ciliogenesis. This is in line with reports on the 
phosphorylation of DBN1 by CDK5 in filopodia formation (Tanabe et al., 2014; 
Worth et al., 2013). Analysis of ciliogenesis in RPE-1 cells expressing the phospho-
mimetic DBN1S142D suggests that the hCDC14A/CDK5 phospho-regulation of S142 
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contributes to cilia length control. Phosphorylation of DBN1S142 by CDK5 relieves an 
intra-molecular interaction within DBN1 and promotes its actin bundling activity 
(Worth et al., 2013). Thus, bundling of actin probably promotes ciliogenesis. 
Presently, it is unclear why DBN1 KO has the same impact on cilia length as 
DBN1S142D. Further studies are required to compare the actin cytoskeleton of DBN1 
KO and DBN1S142 cells and whether cilia elongation in both mutant cell types has the 
same molecular cause. 
CDK5 has been implicated in cilia length regulation since this kinase 
phosphorylates the cilia disassembly factor NDE1 promoting its ubiquitination by 
the E3 ligase FBW7 and the subsequent degradation by the proteasome (Maskey et 
al., 2015). However, Maskey et al. indicated that the CDK5-FBW7-NDE1 brunch is 
only one of several possible modes of action of CDK5 in cilia length control. NDE1 
levels were not affected in hCDC14APD/PD cells during ciliogenesis and hCDC14APD 
cells disassembled cilia even slightly faster than Wt cells in response to serum 
addition. Furthermore, NDE1 was not identified in the hCDC14A phospho-
proteome or BioID screens. This together suggests that NDE1 is not a substrate of 
hCDC14A. Rather, CDK5 affects cilia length in at least two ways: via NDE1 and 
DBN1 (Maskey et al., 2015). While NDE1 regulation reflects the untimely activation 
of a cilia disassembly factor during ciliogenesis, phospho-regulation of DBN1 may 
contribute to cilia length control that is seen between tissues. Additional experiments 
are needed to test this model. 
 How does phospho-regulation of DBN1 affect cilia length? DBN1 was 
reported to function in ectosome release from the tip of the exposed cilia (Nager et 
al., 2017). Ectocytosis is a selective process that removes activated signalling 
molecules from cilia. However, in RPE-1 cells that assemble cilia via the intracellular 
pathway, DBN1 was not detected at the tip of the cilia. This suggests that DBN1 
functions differently in RPE-1 cells. DBN1 negatively regulates endocytosis in 
HEK292 cells (Li et al., 2017). Endocytosis promotes ciliogenesis by delivering 
preciliary vesicles to the basal body (Kim et al., 2010). Interestingly, we observed an 
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increase uptake to transferrin in hCDC14APD RPE-1 cells. We therefore suggest that 
hCDC14A and CDK5 regulate cilia length, at least in part, through phospho-
regulation of DBN1 that then controls the delivery of preciliary vesicles to the basal 
body through endocytosis (Figure 3.1). 
 
Figure 3.1: Proposed model for the elongation of primary cilia in RPE-1 
hCDC14APD cells.  
 
Apart from DBN1, several other proteins such as CEP170, DPYSL2, LIMA1 and 
MAP4 were identified as substrates for hCDC14A. Centrosomal protein of 170 kDa 
(CEP170) is a sub-distal appendage protein which is important for the maturation of 
mother centriole and microtubule anchoring at centrosomes (Huang et al., 2017). 
However, loss of CEP170 affects neither the length of primary cilia nor the 
percentage of ciliated cells, but alters the spatial configuration of cilia (Mazo et al., 
2016). Dihydropyrimidinase-related protein 2 (DPYSL2), which is also known as 
Collapsin response mediator protein 2 (CRMP2), is a substrate for CDK5 and was 
reported to be involved in affecting cilia length by altering microtubule dynamics 
(Husson et al., 2016). In cystic kidney disease, both total CRMP2 and pCRMP2 
(Ser522) are increased, whereas, inhibition of CDK5 activity leads to the reduction of 
CRMP2 and pCRMP2. Microtubule-associated protein 4 (MAP4) was reported to be 
localized to the axoneme where it negatively regulated ciliogenesis (Ghossoub et al., 
2013). Thus hCDC14A has the potential to affect cilia length by modulating 
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axonemal microtubule dynamics through DPYSL2 and MAP4. The actin bundler 
protein LIMA1 might also regulate local pericentrosomal as well as cellular actin 
cytoskeletal status.  
In general, enrichment of actin related proteins in both global phospho-proteome 
and BioID analyses indicates a close connection between hCDC14A function and  
cellular actin regulation. Such cytoskeletal regulation might lead to the alteration of a 
plethora of cellular processes including ciliogenesis, hearing, and fertility. For 
hearing, the epidermal growth factor receptor pathway substrate 8 (EPS8), an actin 
filament remodelling protein that interact with Rab5 GTPase-activator RNtre, was 
proposed to be a substrate for hCDC14A (Imtiaz et al., 2018; Lanzetti et al., 2007). 
However, a precise molecular understanding of the mechanism(s) that govern 
hearing loss in hCDC14A mutants is missing. Another key question that remain 
unresolved is that how hCDC14A is regulated during cell cycle or ciliogenesis. One 
possible mode could be the cell cycle dependent distinct localizations of hCDC14A. 
In such case, the non-conserved variable C-terminal sequence of hCDC14A may be 
involved in determining its localization to exact intracellular compartments (Imtiaz 
et al., 2018). However, post-translational modification dependent regulation could 
also be critical for both localization and function of hCDC14A. 
Conclusion 
60 
 
4 Concluding Remarks 
In this study, we have employed state-of-the-art gene editing techniques to generate 
hCDC14A and/or hCDC14B knockout cell lines to decode molecular mechanisms of 
their functions. The phenotypic analysis of these generated cells was aided by 
various imaging, biochemical and mass-spectrometry techniques. Taking all the 
findings of this study into consideration, we can conclude that – 
▪ hCDC14A and hCDC14B phosphatases are dispensable for cell cycle 
progression in RPE-1 and HCT 116 cells. 
▪ hCDC14A is localized to the proximal end (C-NAP1-dependent) and the sub-
distal appendage regions of mother centriole (basal body). 
▪ Lack of hCDC14A phosphatase activity in RPE-1 cells causes the elongation of 
primary cilia. 
▪ The elongated cilia in hCDC14APD cells are structurally comparable to those 
from Wt cells. 
▪ Regulated expression of hCDC14A but not its phosphatase dead version 
suppresses cilia formation. 
▪ S142 of DBN1 is a substrate for hCDC14A. 
▪ CDK5 kinase and CDC14A phosphatase regulated phospho-status of DBN1 
pS142 is crucial for cilia length control. 
▪ hCDC14APD cells show enhanced recycling endosomes (transferrin) as well as 
increased ciliary vesicle docking (smoothened) in the pericentrosomal areas. 
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5 Materials and Methods 
5.1 Cell culture and transfection 
RPE-1, HEK293T (human embryonic kidney) and HEK293-GP (GP2-293, Clontech) 
cells were cultured in Gibco DMEM/F-12 (ThermoFisher) media containing 10% 
FBS, 1% L-glutamine and 1% penicillin/streptomycin.  HCT116 cells were cultured 
in McCoy’s 5A (Gibco) medium supplemented with 10% FBS, 1% L-glutamine and 
1% penicillin/streptomycin. All cell lines were cultured at 37 °C with 5% CO2. For 
HCT116 cells, fibronectin (Santa Cruz, sc-29011) coatings were made by incubating 
glass coverslips with 5 µg/cm2 of fibronectin in PBS for 30 min at 37 °C. Plasmid 
DNA transfections were made according to manufacturer’s protocol using 
Lipofectamine 2000 or Lipofectamine LTX (RPE-1 cells). Lipofectamine RNAiMAX 
transfection reagent (ThermoFisher) was used according to the manufacturer’s 
instructions with a final concentration of 20 nM siRNA (please see Table 1 and Table 
2 for details of used siRNA). 
 
Table 1: List of ON-TARGETplus SMARTpool siRNA Reagents – Human 
(Dharmacon) 
Catalog Number Gene Symbol siRNA Sequence (5´-3´) 
LU-003469-00 CDC14A GGACAUUGAUAGCCUGUUA 
LU-003469-00 CDC14A CUUGUGAGUUCAUGAAAGA 
LU-003469-00 CDC14A GCACAGUAAAUACCCACUA 
LU-003469-00 CDC14A GAACAUUAUGAGCGAGUUG 
L-003239-00 CDK5 UAUAAGCCCUAUCCGAUGU 
L-003239-00 CDK5 CCGGGAGACUCAUGAGAUC 
L-003239-00 CDK5 GGGCUGGGAUUCUGUCAUA 
L-003239-00 CDK5 GGAUUCCCGUCCGCUGUUA 
L-010508-00 CTTN CCACGAAUAUCAGUCGAAA 
L-010508-00 CTTN GAACAAGACCGAAUGGAUA 
L-010508-00 CTTN GAGCAUAUCAACAUACACA 
L-010508-00 CTTN CAAGUAACAUCAGAGCUAA 
L-011841-00 DBN1 GGAGGAGGCAGCAGCUAUU 
L-011841-00 DBN1 GGAUUAACCGAGAGCAGUU 
L-011841-00 DBN1 CCUCAAGCUUGCAGCAUCA 
L-011841-00 DBN1 GGAGUUUGCCCAAUCGGAA 
L-031725-00 DOCK7 GAUCGAAGUUGUAAUCGUA 
L-031725-00 DOCK7 UCUCGAAGCCUUAGUAAUA 
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Catalog Number Gene Symbol siRNA Sequence (5´-3´) 
L-031725-00 DOCK7 CGACUCUGCUUUAAAGAUU 
L-031725-00 DOCK7 UAACCAAACUUGCAGAGAU 
L-009519-01 DPYSL2 CCGGGAUAUUGGCGCCAUA 
L-009519-01 DPYSL2 GGUCAAACCUAAACACCGA 
L-009519-01 DPYSL2 GAACUGUGGUGUAUGGCGA 
L-009519-01 DPYSL2 AGUUAAAACCUGACGAUUU 
L-003977-00 IGF2BP1 CGAAACACCUGACUCCAAA 
L-003977-00 IGF2BP1 UGAAGGCCAUCGAAACUUU 
L-003977-00 IGF2BP1 GAAAGUAGAAUUACAAGGA 
L-003977-00 IGF2BP1 GCUUAGAGAUUGAACAUUC 
L-027345-00 KANK2 CGUGCGAUCUAUCAUGAAA 
L-027345-00 KANK2 CAGCUCACAGUACAACUUA 
L-027345-00 KANK2 GACGAGAGCCCUACAUCAU 
L-027345-00 KANK2 GAACGGGACUUGGGCAUGC 
L-019252-00 LMO7 GAUGAUUACUCCACAAAUA 
L-019252-00 LMO7 GAAAGCUUGUGAACAGAUU 
L-019252-00 LMO7 AGAGAGAGAAUUCCAAGUA 
L-019252-00 LMO7 UAGCAGGAUUGGAUAAUAU 
L-013027-01 LUZP1 AAGAAAUGACCUACGGAUU 
L-013027-01 LUZP1 GAAGACAACACGAACGUUU 
L-013027-01 LUZP1 GAGUUUAGCGUCAGAGUUA 
L-013027-01 LUZP1 AUAACGACCUUCAGGAUAA 
L-011724-01 MAP4 GGAGUAGAAGGGAGCGAUA 
L-011724-01 MAP4 GGAGAGAUAAAGCGGGACU 
L-011724-01 MAP4 GAUGAUGUUGUGGGAGAAA 
L-011724-01 MAP4 GAGUCAAAGAAGAAACCGU 
L-014102-01 MPRIP CGGGACAAGAAGUACGCAA 
L-014102-01 MPRIP GUGCCACGGUGUCCGGAUA 
L-014102-01 MPRIP GUGCACCGGUCUCGGAAAU 
L-014102-01 MPRIP CGGGUAAAGGAAUCGGAAA 
L-023376-01 MTCL1 GCAGUACCGUCUUCGGAAA 
L-023376-01 MTCL1 CCGAGAGUGAUGCGGGCAA 
L-023376-01 MTCL1 GGAUGAGCGUGCCCGACUA 
L-023376-01 MTCL1 CAGCAAUAUGCCAGCGACA 
L-013081-00 PDLIM7 GCACCGAGUUCAUGCAAGA 
L-013081-00 PDLIM7 UCACACACAUCGAAGCUCA 
L-013081-00 PDLIM7 GAGCAUCGAUGGCGAGAAU 
L-013081-00 PDLIM7 CGGAUGAGGAGCACCUGAA 
L-013299-01 PRRC2A CCAAAUAUCAGAAGUCGUU 
L-013299-01 PRRC2A GGACUCAGACUUACGCCUA 
L-013299-01 PRRC2A CCUGCAGAGUCUCGGGAAA 
L-013299-01 PRRC2A GGAAAGGGAGUCUGCCGAA 
L-004746-00 RANBP2 GCGAAGUGAUGAUAUGUUU 
L-004746-00 RANBP2 CAAACCACGUUAUUACUAA 
L-004746-00 RANBP2 CAGAACAACUUGCUAUUAG 
L-004746-00 RANBP2 GAAGGAAUGUUCAUCAGGA 
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Catalog Number Gene Symbol siRNA Sequence (5´-3´) 
L-006846-00 RANGAP1 GACCGAAUGUCACCGGAAA 
L-006846-00 RANGAP1 UGUACAAGGUCUAGACUCA 
L-006846-00 RANGAP1 GAAACCGUCUGGAGAAUGA 
L-006846-00 RANGAP1 GCAAGAGCCUCAAACUCAA 
L-013690-00 RPS2 UUAAGGAAUCAGAGAUCAU 
L-013690-00 RPS2 CGUCAAGACCCACACCAGA 
L-013690-00 RPS2 CAUGAUGGCUGGUAUCGAU 
L-013690-00 RPS2 AGUGGAUGCCCGUCACCAA 
L-010500-00 SCRIB GACCGCGUCCUCUCUAUUA 
L-010500-00 SCRIB GGACGACGAGGGCAUAUUC 
L-010500-00 SCRIB CGACAGAGCUGCACGUGCU 
L-010500-00 SCRIB ACAACGAGAUCCAGCGGUU 
L-026032-01 SEC16A GGACGGAAGCCUAUGAGUA 
L-026032-01 SEC16A CCUUACAGGAGACGGGCUA 
L-026032-01 SEC16A AAGCGGACUUUGACGAUUU 
L-026032-01 SEC16A CCUCAGUCCUCUAGCGUGU 
L-010657-01 SND1 GGAAGUCUGUUUCACGAUA 
L-010657-01 SND1 UGAUGGAGAACAUGCGCAA 
L-010657-01 SND1 CGAGAGUUCCUUCGAAAGA 
L-010657-01 SND1 UCAUGGUGGAGGUGCGCAA 
L-011479-01 SORBS2 AGCAAGAGGAGGCGAGUUA 
L-011479-01 SORBS2 GGUAAAGAAACAUCGUUGA 
L-011479-01 SORBS2 AAAUAAAAGCCUUCGGUAA 
L-011479-01 SORBS2 UUGUAAAGUUGCAUCGCUA 
L-021390-01 SYNPO AAUCAGAACCCACCGGCAA 
L-021390-01 SYNPO CCAGAGAAGCUACGCUCAU 
L-021390-01 SYNPO CCACCAAGCAGCCGCCAUA 
L-021390-01 SYNPO GAGAAAUAUGUCAUCGAGU 
L-021220-01 UBAP2L CAACACAGCAGCACGUUAU 
L-021220-01 UBAP2L GUGUGGAGAGUGAGGCGAA 
L-021220-01 UBAP2L CAACAGAACCAGACGCAGA 
L-021220-01 UBAP2L CCUGGGAGAUGGUCGGGAA 
L-006099-00 USP9X AGAAAUCGCUGGUAUAAAU 
L-006099-00 USP9X ACACGAUGCUUUAGAAUUU 
L-006099-00 USP9X GUACGACGAUGUAUUCUCA 
L-006099-00 USP9X GAAAUAACUUCCUACCGAA 
In all the siRNA experiments, ON-TARGETplus Non-Targeting Control siRNA 
(Dharmacon D-001810-01-20; 5´-UGUUUACAUGUCGACUAA-3´) was used as 
control. 
Table 2: List of Silencer® Select siRNAs from Ambion®. 
Gene Symbol siRNA Sequence (5´-3´) 
CEP170 GCAUGAGAAGUUUACCAU 
LIMA1 UUAUAGAGGUUUCUGAGAGGCGUGG 
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5.2 Generation of ZFN-mediated knockout cells 
Human CDC14A and CDC14B specific CompoZrTM knockout Zinc Finger Nucleases 
(ZFN) were designed and evaluated by Sigma Advanced Genetic Engineering Labs. 
The ZFN for hCDC14A (product Number: CKOZFND2170-1KT) targets the sequence 
5’-AGCACACCCAGTGACaacatCGTGCGAAGGTTCCTGAA-3’ in the 9th exon 
(cutting site in lower cases). Target sequence for ZFN against hCDC14B is in the 4th 
exon 5’-TGCTGCCTTCCTTGTtggatGCTACATGGTAAGTATTTG-3’ (product 
Number: CKOZFND5769-1KT). The donor vector was constructed by PCR 
amplification of the genomic locus as described in the previous publications from 
our group (Chen et al., 2016; Panic et al., 2015). In short, the genomic locus 800 bp 
upstream and downstream of the ZFN cut site was amplified and sub-cloned into 
pJet 1.2 vector. The insertion cassette including STOP codon in every frame and 
neomycin/ puromycin resistance was inserted at the cut site of donor vector. 
106 cells were co-transfected with the ZFN mRNAs (2.5 µg of each) and donor vector 
(7 µg) by electroporation (Invitrogen, Neon transfection system). After 
electroporation, cells were cultured for 24 hours at 37 ºC (recovery) followed by 48 
hours at 30 ºC (enhancing ZFN efficiency (Doyon et al., 2010)). Cells were further 
cultured at 37 ºC for 72 hours prior to single cell dilution (limiting) in 96 well plates 
(500 µg/ml neomycin). Two weeks later, the emerging clones were screened by 
genomic PCR and positive clones were further confirmed by RT-PCR as well as 
Southern blot hybridization. Junction PCR with one primer in donor construct and 
the other in the genome outside homology arm confirmed successful targeting and 
insertion of the selection markers. The following primers were used for junction PCR 
- hCDC14A: forward 5´-CGGCTATGACTGGGCACAAC-3´; reverse 5´- 
GCCTCCTCGAAGTCAAACAAG -3´; hCDC14B (for NeoR insertion): forward 5´-
CGGCTATGACTGGGCACAAC-3´; reverse 5´-CGATCTCCGCTCACTG-3´; 
hCDC14B (for PuroR insertion): forward 5´-CGGGGCGAAGGCAAC-3´; reverse 5´-
CGATCTCCGCTCACTG-3´. Similar approach without the donor construct was 
taken in case of NHEJ-facilitated disruption of hCDC14B gene. The resultant 
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insertion/deletion-mediated mutagenesis was detected by sequencing of the 
amplified (Q5® High-Fidelity DNA Polymerase - NEB) genomic locus surrounding 
the ZFN cut site (primers used - forward 5´-TGAATGGTTATGGGATTTGGA-3´; 
reverse 5´-GCACAGCTTCCTTGAATTGG-3´). 
 
5.3 Generation of Cas9-mediated hCDC14A knockout cells 
Guide RNAs (gRNAs) targeting the exon 9 of hCDC14A was designed using the web 
tool (http://crispr.mit.edu/ (Hsu et al., 2013)). gRNA1 (5’-
CCAGTGACAACATCGTGCGA-3’), gRNA2 (5’-CCTTCGCACGATGTTGTCAC-3’) 
and gRNA5 (5’-CTTCGCACGATGTTGTCACT-3’) with scores 96, 91 and 86, 
respectively, were selected as they were exactly targeting the ZFN binding site (5’-
AGCACACCCAGTGACaacatCGTGCGAAGGTTCCTGAA-3’). ‘Churh gRNA insert’ 
containing the U6 promoter and gRNA scaffold (Mali et al., 2013) was first 
synthesized as gBlock from IDT (http://www.idtdna.com/pages/products/ 
genes/gblocks-gene-fragments) and cloned into pJet1.2 vector. The intended gRNAs 
were then ordered as PCR primers with overhangs from U6 promoter and gRNA-
scaffold and inserted between U6 promoter and gRNA scaffold through PCR 
mutagenesis. 
Different strategies were used to generate Cas9-mediated hCDC14A-KO HCT116 and 
RPE1 cells. For HCT116, hCas9 plasmid (a gift from George Church (Addgene # 
41815, (Mali et al., 2013))) was transiently transfected with gRNA and donor 
plasmids. Whereas for RPE1 cells, pCW-Cas9 plasmid (a gift from Eric Lander & 
David Sabatini (Addgene # 50661 (Wang et al., 2014))) containing doxycycline (Dox) 
inducible spCas9 was lentivirally integrated into RPE1 FRT/T-Rex cells. Successful 
expression and nuclear localization of Cas9 was confirmed by indirect 
immunofluorescence and western blot analysis. The cells were then electroporated 
with the plasmids containing gRNA and donor vector. Junction PCR with forward 
primer in NeoR cassette (5’-CGGCTATGACTGGGCACAAC-3’) and reverse primer 
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in the genome outside homology arms (5’-GCCTCCTCGAAGTCAAACAAG-3’) 
confirmed successful targeting and insertion of the selection marker. 
 
5.4 Southern blot hybridization to confirm knockouts 
Genome editing in both RPE1 and HCT116 cells was verified by Southern blot 
hybridization (Southern, 2006). Genomic DNA was isolated using MasterPure DNA 
purification kit (Epicentre, Cat MCD85201) following manufacturer’s instructions. 
20 µg of DNA were digested overnight with FastDigest Hind III-HF (Thermo 
Scientific) and run overnight onto a long (18 cm) 0.8% agarose gel at 30-35 V. The gel 
was subsequently stained and photographed (fluorescent ruler of gel-casting tray 
was used to track the distance of migration of DNA bands). The gel was then 
washed in double distilled water (ddH2O) and DNA was denatured in 0.5 M NaOH, 
1.5 M NaCl (twice for 20 min with gentle shaking). After rinsing once with ddH2O, 
DNA was neutralized by washing thrice for 15 min with 1.5 M NaCl, 0.5 M Tris-HCl 
(pH 7.0) and transferred onto a GeneScreen Plus® Hybridization Transfer Membrane 
(PerkinElmer) by overnight capillary transfer in 10xSSC buffer (1.5 M NaCl, 0.15 M 
trisodium citrate). After rinsing the membrane with 2XSSC buffer, DNA was UV-
crosslinked with a Stratalinker 1800 (Stratagene). 
The membrane was hybridized overnight in DIG Easy Hyb buffer (Roche, 
cat#11603558001) with DIG labeled probe generated by PCR DIG probe Synthesis kit 
(Roche, cat#11636090910). Primers used to generate DIG probes for hCDC14A: 
forward 5´-CATCGCCGTTCACTGC-3´, reverse 5´-ACGTGGGCCTGGAAAG-3´; 
and hCDC14B: forward 5´-GCCCAACTACTTTGGCAAAG-3´, reverse 5´- 
CCAATGATCCAAATGGAGCAC-3´. 
 
5.5 RNA preparation and expression analysis 
Total RNA was isolated from cells using the RNeasy Mini Kit (Qiagen, Hilden, 
Germany) following manufacturer’s instructions. RT-PCR analysis confirming 
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expression of wild type and exon-skipped hCDC14A/B transcripts were carried out 
using SuperScript® III One-Step RT-PCR System with Platinum® Taq DNA 
Polymerase (Invitrogen). Forward primer binding to 8th exon (5’-
ATGGTGACTTCAACTGGA-3’) and reverse primer binding to 10th exon (5’-
CTTCCAGGAAGTGCTGC-3’) were used for RT-PCR of hCDC14A coding sequence 
(CDS). In case of hCDC14B, the forward primer was designed in the 2nd exon (5’-
GCCATTCTCTACAGCAG-3’) while reverse primer in 6th exon (5’-
GCAACTTCCATAGGCAGC-3’). Bands corresponding to wild type and exon-
skipped clones were excised from the gel and sequenced to verify the presence of the 
splice junctions (hCDC14A: exon 8-10; hCDC14B: exon 3-5). Human GAPDH was 
amplified with the primers described by Zhang et al (2007): forward 5’-
ATCCCATCACCATCTTCCAG-3’ and reverse 5’-CCATCACGCCACAGTTTCC-3’. 
For semi-quantitative RT-PCR, 40 ng of total RNA was used as template and the 
relative amount of mRNA in different samples was calculated by measuring the 
band intensity (normalized to GAPDH) using NIH ImageJ software (Carbery et al., 
2010) . 
 
5.6 Generation of RPE-1 stable cell lines 
RPE-1 cells with inducible expression of proteins of interest were constructed using 
retroviral-mediated integration as previously described (Vlijm et al., 2018). RPE-1 
tetR cell line with the tetON system was generated according to the manufacturer’s 
instructions (Retro-X Tet-On 3G, Clontech).  The virus particles were first generated 
by co-transfecting the pRetroX-TRE3G vector carrying the gene of interest and the 
envelope vector pCMV-VSV-G (a gift from Bob Weinberg; Addgene plasmid # 8454; 
(Stewart et al., 2003)) to a HEK293-based retroviral packaging cell line (GP2-293, 
Clontech). Then, the RPE-1-tetR cells were infected by adding the virus-containing 
media and 72 hours later, the positively transduced cells were enriched either by 
puromycin selection or FACS sorting.  
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5.7 Generation of Cas9-mediated DBN1 knockout cells 
CRISPR/Cas9-Mediated drebrin knockout was generated by targeting three 
different exons with three guide RNAs (gRNA1: GTACGGCTTCTGCAGTGTCA for 
exon 3; gRNA2: GCAGCGGCTCTCTAACGGGC for exon 5; and gRNA3: 
GGAGCGCGAGCGGCGCTACC for exon 7). The gRNAs were designed using the 
web tool (crispr.mit.edu/), ordered as primers and inserted next to the U6 promoter 
in the scaffold vector pSpCas9(BB)-2A-GFP(PX458) (a gift from Feng Zhang, Broad 
Institute of MIT and Harvard, Cambridge, MA; Addgene plasmid #48138) (Hsu et 
al., 2013; Ran et al., 2013). The plasmid pX458 with gRNA were electroporated into 
RPE-1 cells (Neon transfection system, Invitrogen; pulse voltage 1,050 V, pulse width 
30 ms, and pulse number 2) and 48 hours later, the transfected cells were selected for 
GFP expression through FACS sorting. The sorted cells were then subjected to clonal 
propagation through limiting dilution on 96-well plate. The emerging clones were 
harvested and screened via sequencing the genomic PCR amplicons (please see the 
Table 3 for primer list). The successfully targeted clones were further confirmed by 
immunoblot analysis. 
Table 3: Primer list for amplifying the gRNA targeted loci in DBN1 gene. 
Primer Name Sequence (5´-3´) 
Dbn1_Exon3_gRNA1_fw_1 AGACCTGACACTCTCCTGATTA 
Dbn1_Exon3_gRNA1_rev_1 CTACACGATAGGGTGCATCTTC 
Dbn1_Exon5_gRNA2_fw_1 CCCTCTTTGCTGGGTACTTT 
Dbn1_Exon5_gRNA2_rev_1 CCAGAACTGCTCTCGGTTAAT 
Dbn1_Exon7_gRNA3_fw_2 GGCACCACCTACCAGAAGAC 
Dbn1_Exon7_gRNA3_rev_2 GCTGTTTCCTCCTGGAACGA 
 
5.8 Immunofluorescence and Microscopy 
Cells were seeded on coverslips ~24 hours before the treatments (starvation +/- 
and/or doxycycline +/- depending on the experimental set up) and washed once 
with PBS prior to fixation. The fixation condition was decided depending on the 
primary antibody used (please see Table 4 for the detailed list of antibodies and 
fixation conditions). 4% paraformaldehyde was used for 10 min at room temperature 
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whereas methanol fixation was carried out at -20 °C for 5 min with ice cold 
methanol. Then the cells were permeabilized with 0.1% Triton-X100 in PBS (10 min 
at room temperature (RT)), incubated with 10% FBS to block unspecific binding and 
incubated with primary antibodies inside a wet chamber for 1 hour. Upon three 
times washing with PBS, the cells were incubated with fluorescently labeled 
secondary antibodies for 30 min at RT, washed thrice and mounted with Mowiol 
(company ?) and dried overnight at RT. DNA was counterstained by adding 
DAPI (4',6-diamidino-2-phenylindole) with the secondary antibody solutions. A 
DeltaVision RT system (Applied Precision) equipped with an Olympus IX71 
microscope was used to image immunofluorescence samples using Softworx 
software (Applied Precision). Comparable samples were always imaged with same 
exposures and intensities as well as the background subtracted images were 
displayed with ImageJ using same Minimum and Maximum brightness. 
 
Table 4: List for commonly used antibodies in immunofluorescence. 
Name Species Dilution Fixation Source 
Acetylated Tubulin Mouse 1:200 Both Invitrogen (32-2700) 
Arl13B Rabbit 1:200 Both 17711-1-AP 
Cep164 Guinea Pig 1:500 Both Gislene Pereira 
Cep170 Mouse 1:500 Methanol Thermo Fisher (72-413-1) 
Cep250 Goat 1:200 Methanol (Panic et al., 2015) 
Cortactin Rabbit 1:100 PFA CST 3503 
DBN1-pS142 Mouse 1:50 PFA Millipore (MABN833) 
DBN1 Mouse 1:10 PFA Progen (MX823) 
Gamma tubulin Mouse 1:1000 Methanol Abchem (ab27074) 
GFP Mouse 1:200 Both Roche (11814460001) 
IFT88 Guinea Pig 1:500 Both Gislene Pereira 
Ninein Rabbit 1:300 Methanol Michel Bornens 
ODF2 Rabbit 1:100 Methanol Gislene Pereira 
Pericentrin Rabbit 1:1000 Methanol Abchem (ab4448) 
Phalloidin  1:500 PFA Invitrogen A34055 
Rootletin-C Rabbit 1:200 Methanol  (Panic et al., 2015) 
Smoothened Rabbit 1:200 Methanol Abchem (ab38686) 
Alexa Fluor 
488/555/647 
(Anti-Mouse/ 
Rabbit/ Goat/ 
Guinea Pig) 
 1:500 Both Invitrogen 
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5.9 Immunoblot analysis 
Cells were seeded on 6 or 12 well plate and lysed directly with Laemmli Buffer 
supplemented with protease inhibitor (Roche; 11 873 580 001), phosphatase inhibitor 
(Roche; 04 906 845 001), phenylmethylsulfonyl fluoride (PMSF) and Benzonase 
(Merck, 101656; 1:500). The lysates were heated at 95 °C for 5 min and centrifuged at 
14,000 rpm for 5 min. Sodium dodecyl sulfate - polyacrylamide gel electrophoresis 
(SDS-PAGE) was performed as previously described (Laemmli, 1970). The 
membranes were blocked in 5% nonfat milk in TBS-T and incubated with 
appropriate primary and secondary antibodies (Table 5). 
 
Table 5: List for commonly used antibodies in immunoblot. 
Name Species Dilution Source 
acetylated α-Tubulin Mouse 1:500 Invitrogen (32-2700) 
Cdc14A Rabbit 1:1000 Zymed (34-8100) 
CDK5 Rabbit 1:1000 CST (2506) 
Cep170 Mouse 1:1000 Thermo Fisher (72-413-1) 
Cortactin Rabbit 1:1000 CST (3503) 
Drebrin Mouse 1:300 Progen (MX823) 
GAPDH Rabbit 1:2000 CST (2118) 
GFP Mouse 1:1000 Roche (11814460001) 
pS142-DBN1 Mouse 1:1000 Millipore (MABN833) 
 
5.10 Measuring Cilia length and protein intensity within a defined region 
of interest (ROI) 
Cilia lengths of the background subtracted images were measured by a semi-
automated ImageJ macro developed and optimized by ZMBH imaging facility. In 
short, the macro finds the best line fit for the channel that represent cilia. The line is 
then skeletonized and inflated to measure the length. Upon mouse click, the macro 
visualizes the processing steps with 400X zoom allowing the poorly processed cilia 
measurements to be discarded. Another macro that allows to select the size of region 
of interest (ROI) as well as to define channels to be measured were used for intensity 
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measurements of signals e.g., transferrin, Arp2, Phalloidin surrounding the 
centrosomes in a 1 to 2 µm radius. If not otherwise mentioned, at least 150 cilia or 
centrosomes were quantified for each experiment and the findings were confirmed 
by at least two independent experiments. The results were expressed as mean ± SD 
(Standard deviation). Prism 7 software (GraphPad) was used for statistical analyses. 
Mean between two groups were compared by t tests whereas multiple inter-group 
differences were analysed by one-way ANOVA (analysis of variance) followed by 
Tukey’s multiple comparison test for post hoc comparisons. 
 
5.11 In Vitro Phosphatase Assay 
DBN1-eGFP construct was transfected into HEK293T cells using polyethylenimine 
(PEI). The cells were harvested by scrapping after 48 hours of transfection and lysed 
with RIPA buffer supplemented with protease inhibitor (Roche; 11 873 580 001), 
phenylmethylsulfonyl fluoride (PMSF) and Benzonase (Merck, 101656; 1:500). The 
DBN1-GFP was immunoprecipitated by GFP-Trap®_A beads (Chromotek) following 
manufacturer’s protocol. Equal amount of bead-captured DBN1 protein was 
incubated with purified hCDC14A in phosphatase assay buffer (30 mM imidazole, 1 
mM DTT, 1 mM EDTA, 150 mM KCl, 1 mM MgCl2, and 25 mM K-Hepes) for 2 hours 
at 30 °C. The products were analyzed on immunoblots following SDS/PAGE. A 
buffer control was used to determine the extent of dephosphorylation by quantifying 
pS142-DBN1/ DBN1 ratio. 
 
5.12 Electron microscopy (in collaboration with Annett Neuner) 
RPE-1 cells were seeded on coverslips and cultured at 3 7°C and 5% CO2 till they 
reached a confluency of 70% to 80%. Cells were rinsed in 100 mM phosphate buffer 
(PBS) three times and then fixed with 2.5% glutaraldehyde (GA) in 50 mM 
cacodylate buffer and 2% sucrose for 30 min at RT. After 5 times washing for 5 
minutes with 50 mM cacodylate buffer, cells were incubated for 40 min in 2% 
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osmium/cacodylate buffer on ice in darkness. Followed by 4 times rinsing with 
dH2O and staining overnight at 4 °C in 0.5% uranyl acetate (in H20). On the 
following day coverslips were rinsed again 4 times with dH2O and via dehydration 
row (40, 50, 70, 80, 90, 95, 100% ethanol). Water was removed by ethanol within the 
cells. Coverslips were immediately placed on capsules filled with Spurr-resin and 
polymerized at 60 °C for 24 to 48 hours. Embedded cells were sectioned using a 
Reichert Ultracut S Microtome (Leica Instruments, Vienna, Austria) to a thickness of 
70 nm. Post-staining with 3% uranyl acetate and lead citrate was performed. Sections 
were imaged at a Jeol JE-1400 (Jeol Ltd., Tokyo, Japan), operating at 80 kV, equipped 
with a 4k x 4k digital camera (F416, TVIPS, Gauting, Germany). Micrographs were 
adjusted in brightness and contrast using ImageJ. 
 
5.13 Quantitative phosphoproteome and BioID mass-spectrometry analyses 
The quantitative phosphoproteome and BioID mass-spectrometry analyses were 
conducted as described before (Chen et al., 2017). For global phosphoproteome 
analysis, RPE-1 cells with inducible expression of hCDC14A-YFP were cultured in 
light (Arg12C14N Lys12C14N) and heavy (Arg13C15N Lys13C15N) SILAC medium 
(Silantes) in separate flasks. After seven passages, cells were expanded to four T175 
flasks for each condition and starved for 48 hours. Doxycycline (10ng/mL) was 
added only to the heavy samples along with starvation for inducing hCDC14A-YFP 
expression. Proteins were extracted and mixed at a ratio of 1:1. Strong cation 
exchange chromatography/immobilized metal affinity chromatography 
(SCX/IMAC) technique was used to enrich phospho-peptides (Villen et al., 2008). 
The resulted 48 fractions (24 phospho-enriched and 24 phospho-depleted) were 
analysed by LC-MS using a Dionex UltiMate 3000RSLC nano HPLC system (Thermo 
Scientific) coupled to a LTQ Orbitrap Elite mass spectrometer (Thermo Scientific). 
Peptide identification and quantification was achieved using the MaxQuant software 
package (1.5.3.8) with its built-in Andromeda search algorithm (Cox and Mann, 
2008). The results of the database search were analysed using Perseus (Tyanova et 
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al., 2016). Two replicates of the experiment were run, and a short list of the results 
are represented in the Table 7 in Appendix section.  
For BioID mass-spectrometry analysis, RPE-1 hCDC14A-BirA-HA, 
hCDC14AC278S-BirA-HA, and BirA-HA cells were cultured in medium containing 50 
µM biotin. Protein expression was induced by adding Doxycycline (10 ng/mL) 
during 48 hours of starvation. The cells were harvested and lysed using RIPA buffer 
[10 mM Tris–Cl, 150 mM NaCl, 1% Triton X-100, 0.1% SDS] supplemented with 
protease inhibitor (Roche; 11 873 580 001), phenylmethylsulfonyl fluoride (PMSF) 
and Benzonase (Merck, 101656; 1:500). The lysate was clarified by centrifuging for 15 
min at 20,000×g and the supernatant was incubated with streptavidin Sepharose 
beads (GE 17-5113-01) at 4 °C for 3 hours. Then the beads were washed thrice with 
RIPA buffer and the bound proteins were eluted by heating at 95 °C for 10 min with 
2X Laemmli buffer containing 2 mM biotin. The samples were dimethyl labelled 
(Heavy – BirA control; Medium - hCDC14ACSBirA and Light – hCDC14A-BirA prior 
to mass spectrometry analysis (Boersema et al., 2009) (Table 8 in the Appendix 
section). 
 
5.14 Flow cytometry 
Cells were trypsinized and washed twice with PBS, followed by fixation using 70% 
ethanol at -20ºC for 3 hours before permeabilization with 0.25% Triton X-100 on ice 
(15 min). Cells were subsequently treated with 250 µg/mL RNase for 30 min at 37 ºC 
before adding 25 µg/ml propidium iodide to stain the DNA for analysis with a BD 
FACS Canto II flow cytometer. For analysing any proteins by FACS, the primary 
antibody solutions in 1% BSA in PBS are added after permeabilization and incubated 
for 90 min at RT. The cells were washed once with 1 ml PBS + 1%BSA and 
appropriate secondary antibodies (1/250 in 1% BSA in PBS) are added and 
incubated for 30 min at RT in dark. After a single wash in PBS, the cells were 
subjected to RNase treatment and DNA staining. 
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5.15  Transformation of E. coli  
50 µl of CaCl2- competent DH5alpha E. coli cells were mixed with 0.5 µl of plasmid 
DNA or 10 µl from ligation reaction on ice for 30 min and heat shock at 42 °C for 1 
min.  Cells were incubated in 1 ml LB-medium at 37 °C for 1 hour by shaking if 
Kanamycin selection was applied afterwards. Cells were spun down and 
resuspended in 200 µl LB medium before bead spreading on antibiotic containing LB 
plates. 
 
5.16 List of plasmids 
During this study different plasmids were generated and details (maps and 
sequences) of all the plasmids can be found in the collection of the Schiebel group 
(Table 6). 
Table 6: List of plasmids 
Name Used for 
pRetroX-TRE3G_hCdc14A-YFP Stable cells 
pRetroX-TRE3G_hCdc14AC278S-YFP Stable cells 
pRetroX-TRE3G_GFP Stable cells 
pRetroX-TRE3G_mSmo-GFP Stable cells 
pRetroX-TRE3G_hCdc14A-BirA-HA Stable cells 
pRetroX-TRE3G_hCdc14AC278S-BirA-HA Stable cells 
pRetroX-TRE3G_BirA-HA Stable cells 
pRetroX-TRE3G_DBN1-GFP Stable cells 
pRetroX-TRE3G_DBN1S142A-GFP Stable cells 
pRetroX-TRE3G_DBN1S142D-GFP Stable cells 
pRetroX-TRE3G_DBN1S141A-S142A-GFP Stable cells 
pRetroX-TRE3G_DBN1S141D-S142D-GFP Stable cells 
pRetroX-TRE3G_IFT20-GFP Stable cells 
pRetroX-TRE3G_mRuby2-Rab8a Stable cells 
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8 Appendix 
Table 7: List of hypophosphorylated peptides upon hCDC14A-YFP expression. 
Gene.names Protein.names Positions Amino 
Acid 
Ratio.H.L. 
normalized 
ABI2 Abl interactor 2 224 S 0.43155 
ABI2 Abl interactor 2 227 S 0.54756 
AKAP10 A-kinase anchor protein 10, 
mitochondrial 
281 S 0.57212 
CARHSP1 Calcium-regulated heat stable 
protein 1 
17 S 0.54136 
DBN1 Drebrin 142 S 0.53107 
DPYSL2 Dihydropyrimidinase-related 
protein 2 
514 T 0.55474 
DPYSL2 Dihydropyrimidinase-related 
protein 2 
521 T 0.46302 
DPYSL2 Dihydropyrimidinase-related 
protein 2 
517 S 0.47602 
DPYSL2 Dihydropyrimidinase-related 
protein 2 
522 S 0.50275 
DPYSL2 Dihydropyrimidinase-related 
protein 2 
518 S 0.47058 
EEF1D Elongation factor 1-delta 133 S 0.39367 
EIF2A Eukaryotic translation initiation 
factor 2A;Eukaryotic translation 
initiation factor 2A, N-terminally 
processed 
501 S 0.54618 
HEATR5B HEAT repeat-containing protein 
5B 
1737 S 0.47532 
IGF2BP1 Insulin-like growth factor 2 
mRNA-binding protein 1 
181 S 0.44091 
KCNMA1 Calcium-activated potassium 
channel subunit alpha-1 
543 S 0.48962 
LARP1B La-related protein 1B 574 S 0.3842 
LIMA1 LIM domain and actin-binding 
protein 1 
610 S 0.45948 
LMO7 LIM domain only protein 7 591 S 0.3737 
MAP4 Microtubule-associated 
protein;Microtubule-associated 
protein 4 
297 S 0.5814 
MAPRE3 Microtubule-associated protein 
RP/EB family member 3 
162 S 0.46471 
MAPRE3 Microtubule-associated protein 
RP/EB family member 3 
161 T 0.51671 
MPRIP Myosin phosphatase Rho-
interacting protein 
365 S 0.57032 
NUF2 Kinetochore protein Nuf2 247 S 0.55403 
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Gene.names Protein.names Positions Amino 
Acid 
Ratio.H.L. 
normalized 
NUP160 Nuclear pore complex protein 
Nup160 
1122 S 0.54839 
PDLIM7 PDZ and LIM domain protein 7 217 S 0.563 
PPP1R18 Phostensin 530 S 0.55116 
PTDSS1 Phosphatidylserine synthase 1 296 S 0.41335 
PURB Transcriptional activator protein 
Pur-beta 
101 S 0.36843 
RANBP2 E3 SUMO-protein ligase RanBP2 2276 S 0.34595 
RANGAP1 Ran GTPase-activating protein 1 442 S 0.30462 
RPRD2 Regulation of nuclear pre-mRNA 
domain-containing protein 2 
923 S 0.17653 
RPS2 40S ribosomal protein S2 264 S 0.54946 
SCRIB Protein scribble homolog 1348 S 0.54901 
SEC16A Protein transport protein Sec16A 1069 S 0.4981 
STUB1 E3 ubiquitin-protein ligase CHIP 19 S 0.49963 
SYNPO Synaptopodin 784 S 0.37795 
SYNPO Synaptopodin 589 S 0.56312 
SZRD1 SUZ domain-containing protein 1 19 S 0.54282 
UBAP2L Ubiquitin-associated protein 2-
like 
609 S 0.51679 
USP9X Probable ubiquitin carboxyl-
terminal hydrolase FAF-X 
2443 S 0.51447 
 
 
  
 Appendix 
92 
 
Table 8: List of proteins identified in hCDC14A BioID proximity assay. 
Gene names Protein names Unique 
peptides 
Ratio H/L 
normalized 
Ratio H/M 
normalized 
AAK1 AP2-associated protein kinase 1 12 -232.634 -208.767 
AASS Alpha-aminoadipic semialdehyde 
synthase, mitochondrial;Lysine 
ketoglutarate 
reductase;Saccharopine 
dehydrogenase 
13 -174.463 -162.313 
ABLIM1 Actin-binding LIM protein 1 10 -255.741 -188.422 
ACAD9 Acyl-CoA dehydrogenase family 
member 9, mitochondrial 
27 -278.448 -263.173 
ACADVL Very long-chain specific acyl-CoA 
dehydrogenase, mitochondrial 
28 -231.933 -17.731 
ACAT1 Acetyl-CoA acetyltransferase, 
mitochondrial 
12 -151.231 -110.392 
ACOT2;ACO
T1 
Acyl-coenzyme A thioesterase 2, 
mitochondrial;Acyl-coenzyme A 
thioesterase 1 
28 -352.017 -338.737 
ACOT9 Acyl-coenzyme A thioesterase 9, 
mitochondrial 
13 -18.039 -170.167 
ACTN1 Alpha-actinin-1 35 -178.513 -38.895 
ACTN4 Alpha-actinin-4 32 -152.745 -147.369 
ADD1 Alpha-adducin 19 -13.105 -198.604 
AFG3L2 AFG3-like protein 2 31 -189.604 -155.733 
AHNAK Neuroblast differentiation-
associated protein AHNAK 
417 -548.597 -645.748 
AHNAK2 Protein AHNAK2 105 -213.651 -188.763 
AKAP2 A-kinase anchor protein 2 13 -200.144 -158.571 
ALDH18A1 Delta-1-pyrroline-5-carboxylate 
synthase;Glutamate 5-
kinase;Gamma-glutamyl phosphate 
reductase 
28 -145.233 -222.176 
ALMS1 Alstrom syndrome protein 1 18 -133.657 -177.685 
ANAPC1 Anaphase-promoting complex 
subunit 1 
25 -246.212 -192.134 
ANAPC5 Anaphase-promoting complex 
subunit 5 
11 -244.733 -182.495 
ANKRD17 Ankyrin repeat domain-containing 
protein 17 
12 -210.011 -127.953 
AP2A1 AP-2 complex subunit alpha-1 12 -14.346 -127.495 
AP3B1 AP-3 complex subunit beta-1 17 -166.827 -199.447 
ARCN1 Coatomer subunit delta 14 -135.424 -156.009 
ARHGAP21 Rho GTPase-activating protein 21 19 -266.722 -215.991 
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Gene names Protein names Unique 
peptides 
Ratio H/L 
normalized 
Ratio H/M 
normalized 
ARHGAP29 Rho GTPase-activating protein 29 17 -233.964 -213.581 
ASCC3 Activating signal cointegrator 1 
complex subunit 3 
38 -178.126 -160.117 
ATAD3A ATPase family AAA domain-
containing protein 3A 
15 -120.929 -137.759 
ATP5A1 ATP synthase subunit alpha, 
mitochondrial 
33 -217.573 -204.139 
ATP5B ATP synthase subunit beta, 
mitochondrial;ATP synthase 
subunit beta 
22 -302.362 -327.914 
ATXN2L Ataxin-2-like protein 19 -199.062 -146.454 
BCR Breakpoint cluster region protein 10 -158.766 -168.971 
BCS1L Mitochondrial chaperone BCS1 11 -148.965 -127.233 
C17orf80 Uncharacterized protein C17orf80 14 -160.283 -194.886 
CAD CAD protein;Glutamine-dependent 
carbamoyl-phosphate 
synthase;Aspartate 
carbamoyltransferase;Dihydroorota
se 
12 -215.862 -205.685 
CALD1 Caldesmon 38 -216.495 -282.941 
CAMSAP2 Calmodulin-regulated spectrin-
associated protein 2 
11 -309.863 -33.823 
CAND1 Cullin-associated NEDD8-
dissociated protein 1 
24 -176.538 -183.126 
CAPZB F-actin-capping protein subunit beta 10 -106.196 -104.552 
CCT2 T-complex protein 1 subunit beta 24 -197.778 -206.407 
CCT3 T-complex protein 1 subunit gamma 23 -167.397 -214.248 
CCT4 T-complex protein 1 subunit delta 21 -282.021 -301.648 
CCT5 T-complex protein 1 subunit epsilon 25 -109.062 -180.738 
CCT6A T-complex protein 1 subunit zeta 16 -114.283 -172.953 
CCT7 T-complex protein 1 subunit eta 24 -115.418 -201.363 
CCT8 T-complex protein 1 subunit theta 38 -360.679 -473.989 
CD2AP CD2-associated protein 33 -294.109 -283.013 
CDC14A Dual specificity protein phosphatase 
CDC14A 
48 -318.744 -339.358 
CDC23 Cell division cycle protein 23 
homolog 
17 -131.646 -170.844 
CEP131 Centrosomal protein of 131 kDa 35 -302.868 -191.855 
CKAP4 Cytoskeleton-associated protein 4 11 -121.508 -165.018 
CLINT1 Clathrin interactor 1 12 -135.045 -145.954 
CLPX ATP-dependent Clp protease ATP-
binding subunit clpX-like, 
mitochondrial 
19 -256.482 -178.876 
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Ratio H/M 
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CLTC Clathrin heavy chain;Clathrin heavy 
chain 1 
16 -205.968 -205.859 
CNOT1 CCR4-NOT transcription complex 
subunit 1 
32 -16.748 -158.273 
COPA Coatomer subunit 
alpha;Xenin;Proxenin 
34 -182.715 -190.498 
COPB1 Coatomer subunit beta 28 -127.879 -153.249 
COPB2 Coatomer subunit beta 16 -161.989 -165.717 
COPG2 Coatomer subunit gamma-2 30 -265.145 -291.191 
CORO1B Coronin-1B 25 -342.762 -30.418 
CORO1C Coronin-1C;Coronin 23 -32.033 -416.385 
CRK Adapter molecule crk 12 -255.334 -262.691 
CSDE1 Cold shock domain-containing 
protein E1 
34 -234.938 -236.848 
CTNND1 Catenin delta-1 24 -201.188 -302.315 
CTPS1 CTP synthase 1 13 -177.226 -178.463 
CYFIP1 Cytoplasmic FMR1-interacting 
protein 1 
11 -167.738 -159.579 
DAP3 28S ribosomal protein S29, 
mitochondrial 
21 -3.423 -322.351 
DARS Aspartate--tRNA ligase, cytoplasmic 15 -211.223 -229.414 
DBN1 Drebrin 11 -132.775 -134.626 
DBT Lipoamide acyltransferase 
component of branched-chain 
alpha-keto acid dehydrogenase 
complex, mitochondrial 
26 -43.166 -417.132 
DCTN1;DKF
Zp686E0752 
Dynactin subunit 1 34 -175.326 -232.388 
DCTN2 Dynactin subunit 2 10 -14.032 -116.188 
DDX1 ATP-dependent RNA helicase 
DDX1 
12 -189.475 -129.846 
DDX21 Nucleolar RNA helicase 2 15 -165.045 -142.341 
DDX3X;DDX
3Y 
ATP-dependent RNA helicase 
DDX3X;ATP-dependent RNA 
helicase DDX3Y 
32 -145.795 -134.979 
DENND4C DENN domain-containing protein 
4C 
17 -230.979 -195.428 
DHX9 ATP-dependent RNA helicase A 32 -11.151 -112.249 
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DLAT Dihydrolipoyllysine-residue 
acetyltransferase component of 
pyruvate dehydrogenase complex, 
mitochondrial;Acetyltransferase 
component of pyruvate 
dehydrogenase complex 
18 -291.159 -270.566 
DLD Dihydrolipoyl dehydrogenase, 
mitochondrial;Dihydrolipoyl 
dehydrogenase 
22 -244.568 -451.655 
DLG5 Disks large homolog 5 86 -272.557 -251.928 
DLST Dihydrolipoyllysine-residue 
succinyltransferase component of 2-
oxoglutarate dehydrogenase 
complex, mitochondrial 
18 -344.941 -335.842 
DNAJC13 DnaJ homolog subfamily C member 
13 
47 -17.134 -153.629 
DNMBP Dynamin-binding protein 45 -227.739 -19.703 
DOCK7 Dedicator of cytokinesis protein 7 35 -177.932 -176.695 
DPYSL2 Dihydropyrimidinase-related 
protein 2 
28 -174.087 -2.044 
DPYSL3 Dihydropyrimidinase-related 
protein 3 
18 -222.075 -23.879 
DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 30 -179.411 -10.858 
EDC4 Enhancer of mRNA-decapping 
protein 4 
23 -187.758 -161.741 
EEF1G Elongation factor 1-gamma 16 -199.522 -242.391 
EFTUD1 Elongation factor Tu GTP-binding 
domain-containing protein 1 
12 -182.808 -183.501 
EIF3A Eukaryotic translation initiation 
factor 3 subunit A 
42 -239.373 -207.686 
EIF3B Eukaryotic translation initiation 
factor 3 subunit B 
15 -175.901 -145.728 
EIF3C;EIF3C
L 
Eukaryotic translation initiation 
factor 3 subunit C;Eukaryotic 
translation initiation factor 3 
subunit C-like protein 
19 -315.804 -251.854 
EIF3E Eukaryotic translation initiation 
factor 3 subunit E 
11 -25.154 -18.594 
EIF3L Eukaryotic translation initiation 
factor 3 subunit L 
15 -243.355 -250.504 
EIF4B Eukaryotic translation initiation 
factor 4B 
15 -328.729 -272.537 
EIF4G1 Eukaryotic translation initiation 
factor 4 gamma 1 
35 -19.443 -181.604 
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EIF4G3 Eukaryotic translation initiation 
factor 4 gamma 3 
22 -20.077 -193.335 
EIF5 Eukaryotic translation initiation 
factor 5 
15 -235.675 -207.467 
EML4 Echinoderm microtubule-associated 
protein-like 4 
14 -213.062 -213.087 
EPB41L2 Band 4.1-like protein 2 18 -188.801 -158.005 
EPB41L3 Band 4.1-like protein 3;Band 4.1-like 
protein 3, N-terminally processed 
15 -175.916 -174.812 
EPHA2 Ephrin type-A receptor 2 15 -167.683 -138.481 
EPRS Bifunctional glutamate/proline--
tRNA ligase;Glutamate--tRNA 
ligase;Proline--tRNA ligase 
38 -162.411 -220.178 
EPS15L1 Epidermal growth factor receptor 
substrate 15-like 1 
26 -164.268 -141.323 
ERBB2IP Protein LAP2 40 -234.652 -195.054 
ERC1 ELKS/Rab6-interacting/CAST 
family member 1 
68 -258.779 -241.596 
ESYT1 Extended synaptotagmin-1 21 -2.124 -160.073 
ESYT2 Extended synaptotagmin-2 10 -184.166 -167.696 
EXOC4 Exocyst complex component 4 19 -206.401 -199.344 
EZR Ezrin 13 -165.845 -325.925 
FAM120A Constitutive coactivator of PPAR-
gamma-like protein 1 
27 -146.678 -219.008 
FAM129B Niban-like protein 1 17 -104.068 -19.771 
FASN Fatty acid synthase;[Acyl-carrier-
protein] S-acetyltransferase;[Acyl-
carrier-protein] S-
malonyltransferase;3-oxoacyl-[acyl-
carrier-protein] synthase;3-oxoacyl-
[acyl-carrier-protein] reductase;3-
hydroxyacyl-[acyl-carrier-protein] 
dehydratase;Enoyl-[acyl-carrier-
protein] reductase;Oleoyl-[acyl-
carrier-protein] hydrolase 
94 -199.183 -227.593 
FLNB Filamin-B 110 -266.731 -284.415 
FLNC Filamin-C 118 -3.769 -393.514 
FXR1 Fragile X mental retardation 
syndrome-related protein 1 
10 -127.355 -175.502 
GAPVD1 GTPase-activating protein and VPS9 
domain-containing protein 1 
22 -179.626 -174.933 
GBF1 Golgi-specific brefeldin A-resistance 
guanine nucleotide exchange factor 
1 
10 -220.583 -199.798 
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GCN1L1 Translational activator GCN1 65 -253.525 -227.991 
GEMIN5 Gem-associated protein 5 36 -158.005 -172.571 
GIGYF2 PERQ amino acid-rich with GYF 
domain-containing protein 2 
35 -247.161 -260.489 
GLUD1;GLU
D2 
Glutamate dehydrogenase 1, 
mitochondrial;Glutamate 
dehydrogenase 2, mitochondrial 
30 -232.735 -213.068 
GOLGA3 Golgin subfamily A member 3 14 -133.308 -146.705 
HAUS3 HAUS augmin-like complex subunit 
3 
14 -162.118 -164.543 
HAUS5 HAUS augmin-like complex subunit 
5 
15 -127.932 -143.319 
HDLBP Vigilin 45 -269.825 -414.242 
HSD17B10 3-hydroxyacyl-CoA dehydrogenase 
type-2 
11 -231.854 -213.334 
HSDL2 Hydroxysteroid dehydrogenase-like 
protein 2 
13 -262.665 -277.873 
HSPA1B;HS
PA1A 
Heat shock 70 kDa protein 1B;Heat 
shock 70 kDa protein 1A 
23 -176.975 -197.551 
HSPA5 78 kDa glucose-regulated protein 38 -231.545 -251.474 
HSPA8 Heat shock cognate 71 kDa protein 23 -242.291 -242.577 
HSPA9 Stress-70 protein, mitochondrial 33 -158.437 -19.463 
IARS Isoleucine--tRNA ligase, 
cytoplasmic 
25 -105.544 -142.717 
IARS2 Isoleucine--tRNA ligase, 
mitochondrial 
34 -372.994 -392.148 
IGF2BP1 Insulin-like growth factor 2 mRNA-
binding protein 1 
11 -171.558 -161.251 
IGF2BP2 Insulin-like growth factor 2 mRNA-
binding protein 2 
16 -266.749 -258.519 
IPO7 Importin-7 11 -144.721 -123.708 
IQGAP1 Ras GTPase-activating-like protein 
IQGAP1 
40 -115.053 -17.092 
KIAA0196 WASH complex subunit strumpellin 13 -302.315 -312.469 
KIAA1033 WASH complex subunit 7 12 -144.501 -214.318 
KIAA1217 Sickle tail protein homolog 15 -261.493 -18.558 
KIAA1671 Uncharacterized protein KIAA1671 50 -244.175 -158.268 
KIF5B Kinesin-1 heavy chain 37 -179.771 -145.724 
KPNB1 Importin subunit beta-1 37 -273.034 -277.932 
KRT18 Keratin, type I cytoskeletal 18 18 -345.263 -313.062 
KTN1 Kinectin 30 -157.734 -139.236 
LARS Leucine--tRNA ligase, cytoplasmic 20 -152.787 -110.045 
 Appendix 
98 
 
Gene names Protein names Unique 
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LETM1 LETM1 and EF-hand domain-
containing protein 1, mitochondrial 
30 -237.079 -18.984 
LIMCH1 LIM and calponin homology 
domains-containing protein 1 
50 -341.018 -19.686 
LPP Lipoma-preferred partner 18 -202.862 -186.533 
LRPPRC Leucine-rich PPR motif-containing 
protein, mitochondrial 
75 -294.053 -257.596 
LUZP1 Leucine zipper protein 1 65 -217.332 -208.724 
MACF1 Microtubule-actin cross-linking 
factor 1, isoforms 1/2/3/5 
36 -201.829 -144.878 
MAP1B Microtubule-associated protein 
1B;MAP1B heavy chain;MAP1 light 
chain LC1 
46 -154.785 -123.396 
MAP4 Microtubule-associated 
protein;Microtubule-associated 
protein 4 
28 -408.792 -43.687 
MAP7D3 MAP7 domain-containing protein 3 13 -184.715 -151.083 
MAPRE2 Microtubule-associated protein 
RP/EB family member 2 
10 -270.134 -219.383 
MAST4 Microtubule-associated 
serine/threonine-protein kinase 4 
14 -283.054 -185.679 
MCM7 DNA replication licensing factor 
MCM7 
18 -120.128 -122.769 
MDH2 Malate dehydrogenase, 
mitochondrial;Malate 
dehydrogenase 
12 -162.238 -101.762 
MKL2 MKL/myocardin-like protein 2 28 -285.194 -238.037 
MPRIP Myosin phosphatase Rho-
interacting protein 
50 -250.038 -233.337 
MRPL1 39S ribosomal protein L1, 
mitochondrial 
12 -157.785 -126.382 
MRPL15 39S ribosomal protein L15, 
mitochondrial 
16 -24.661 -21.334 
MRPL19 39S ribosomal protein L19, 
mitochondrial 
10 -341.648 -310.495 
MRPL28 39S ribosomal protein L28, 
mitochondrial 
10 -162.482 -137.565 
MRPL37 39S ribosomal protein L37, 
mitochondrial 
20 -253.349 -209.302 
MRPL38 39S ribosomal protein L38, 
mitochondrial 
14 -22.477 -185.872 
MRPL39 39S ribosomal protein L39, 
mitochondrial 
13 -247.361 -217.821 
MRPL4 39S ribosomal protein L4, 
mitochondrial 
10 -298.188 -226.708 
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MRPL44 39S ribosomal protein L44, 
mitochondrial 
12 -174.676 -181.188 
MRPL9 39S ribosomal protein L9, 
mitochondrial 
11 -350.476 -306.106 
MRPS18B 28S ribosomal protein S18b, 
mitochondrial 
12 -349.761 -341.551 
MRPS2 28S ribosomal protein S2, 
mitochondrial 
10 -233.439 -262.531 
MRPS22 28S ribosomal protein S22, 
mitochondrial 
18 -334.511 -278.677 
MRPS27 28S ribosomal protein S27, 
mitochondrial 
20 -344.758 -31.428 
MRPS30 28S ribosomal protein S30, 
mitochondrial 
10 -170.139 -168.427 
MRPS31 28S ribosomal protein S31, 
mitochondrial 
18 -230.287 -204.311 
MRPS34 28S ribosomal protein S34, 
mitochondrial 
13 -332.516 -273.178 
MRPS35 28S ribosomal protein S35, 
mitochondrial 
15 -261.476 -210.774 
MRPS5 28S ribosomal protein S5, 
mitochondrial 
17 -217.338 -216.527 
MRPS7 28S ribosomal protein S7, 
mitochondrial 
14 -259.396 -225.498 
MRPS9 28S ribosomal protein S9, 
mitochondrial 
22 -258.753 -249.834 
MSN Moesin 11 -237.527 -205.439 
MTCL1 Microtubule cross-linking factor 1 19 -279.927 -248.149 
MTHFD1L Monofunctional C1-tetrahydrofolate 
synthase, mitochondrial 
13 -206.631 -186.292 
MYH10 Myosin-10 43 -211.466 -16.291 
MYH9 Myosin-9 178 -494.484 -599.806 
MYO18A Unconventional myosin-XVIIIa 17 -192.517 -110.058 
MYO1B Unconventional myosin-Ib 22 -140.446 -156.854 
MYO1C Unconventional myosin-Ic 28 -166.594 -161.228 
MYO5A Unconventional myosin-Va 15 -164.562 -125.384 
MYO6 Unconventional myosin-VI 11 -15.014 -124.274 
MYOF Myoferlin 39 -184.773 -193.633 
NAP1L4 Nucleosome assembly protein 1-like 
4 
10 -196.162 -189.293 
NCKAP1 Nck-associated protein 1 13 -115.817 -146.973 
NCL Nucleolin 14 -105.218 -112.759 
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NDUFA9 NADH dehydrogenase 
[ubiquinone] 1 alpha subcomplex 
subunit 9, mitochondrial 
14 -347.881 -256.619 
NDUFS1 NADH-ubiquinone oxidoreductase 
75 kDa subunit, mitochondrial 
42 -330.031 -300.243 
NDUFS2 NADH dehydrogenase 
[ubiquinone] iron-sulfur protein 2, 
mitochondrial 
22 -2.662 -241.974 
NDUFS3 NADH dehydrogenase 
[ubiquinone] iron-sulfur protein 3, 
mitochondrial 
17 -314.051 -257.021 
NDUFV1 NADH dehydrogenase 
[ubiquinone] flavoprotein 1, 
mitochondrial 
23 -267.586 -236.223 
NDUFV2 NADH dehydrogenase 
[ubiquinone] flavoprotein 2, 
mitochondrial 
10 -236.312 -206.148 
NDUFV3 NADH dehydrogenase 
[ubiquinone] flavoprotein 3, 
mitochondrial 
24 -377.391 -304.228 
NEK1 Serine/threonine-protein kinase 
Nek1 
17 -159.118 -173.154 
NEXN Nexilin 14 -355.543 -226.951 
NNT NAD(P) transhydrogenase, 
mitochondrial 
19 -193.501 -203.074 
NT5DC2 5-nucleotidase domain-containing 
protein 2 
14 -159.244 -175.867 
NUP214 Nuclear pore complex protein 
Nup214 
42 -135.038 -179.436 
NUP88 Nuclear pore complex protein 
Nup88 
15 -154.422 -176.601 
OFD1 Oral-facial-digital syndrome 1 
protein 
19 -241.442 -162.919 
OGDH 2-oxoglutarate dehydrogenase, 
mitochondrial 
55 -278.886 -275.419 
OTUD4 OTU domain-containing protein 4 12 -234.373 -205.475 
PABPC1;PAB
PC3 
Polyadenylate-binding 
protein;Polyadenylate-binding 
protein 1;Polyadenylate-binding 
protein 3 
12 -204.311 -190.574 
PACS1 Phosphofurin acidic cluster sorting 
protein 1 
10 -156.162 -120.806 
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PAICS Multifunctional protein 
ADE2;Phosphoribosylaminoimidaz
ole-succinocarboxamide 
synthase;Phosphoribosylaminoimid
azole carboxylase 
14 -16.218 -128.026 
PALLD Palladin 37 -143.195 -163.249 
PARP4 Poly [ADP-ribose] polymerase 4 55 -256.602 -222.735 
PDLIM1 PDZ and LIM domain protein 1 17 -143.327 -121.307 
PDLIM4 PDZ and LIM domain protein 4 13 -213.214 -230.251 
PDLIM5 PDZ and LIM domain protein 5 28 -333.625 -323.555 
PDLIM7 PDZ and LIM domain protein 7 14 -228.694 -189.223 
PDPR Pyruvate dehydrogenase 
phosphatase regulatory subunit, 
mitochondrial 
16 -15.655 -14.323 
PEAK1 Pseudopodium-enriched atypical 
kinase 1 
21 -122.597 -179.786 
PHB Prohibitin 18 -289.604 -270.237 
PHB2 Prohibitin-2 18 -36.678 -330.173 
PLEC Plectin 40 -20.095 -188.892 
PLEKHA5 Pleckstrin homology domain-
containing family A member 5 
32 -269.947 -23.734 
PNPLA8 Calcium-independent 
phospholipase A2-gamma 
13 -274.923 -182.434 
PPFIA1 Liprin-alpha-1 16 -161.295 -189.502 
PPFIBP1 Liprin-beta-1 29 -204.204 -133.555 
PPP1R9B Neurabin-2 22 -308.277 -313.302 
PPP6C Serine/threonine-protein 
phosphatase 6 catalytic 
subunit;Serine/threonine-protein 
phosphatase 6 catalytic subunit, N-
terminally processed 
12 -126.979 -198.879 
PPP6R1 Serine/threonine-protein 
phosphatase 6 regulatory subunit 1 
17 -193.545 -174.758 
PPP6R2 Serine/threonine-protein 
phosphatase 6 regulatory subunit 2 
26 -184.752 -177.655 
PPP6R3 Serine/threonine-protein 
phosphatase 6 regulatory subunit 3 
12 -171.781 -146.391 
PRKDC DNA-dependent protein kinase 
catalytic subunit 
42 -159.166 -147.823 
PRRC2A Protein PRRC2A 31 -223.175 -166.392 
PRRC2C Protein PRRC2C 32 -236.045 -146.857 
PSMC2 26S protease regulatory subunit 7 11 -165.513 -140.095 
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PSMD2 26S proteasome non-ATPase 
regulatory subunit 2 
11 -201.293 -156.303 
PSMD3 26S proteasome non-ATPase 
regulatory subunit 3 
17 -148.362 -143.269 
PTCD3 Pentatricopeptide repeat domain-
containing protein 3, mitochondrial 
27 -314.893 -318.968 
PTK2 Focal adhesion kinase 1 10 -121.488 -173.078 
PTRF Polymerase I and transcript release 
factor 
10 -254.532 -241.411 
PYCR1 Pyrroline-5-carboxylate reductase 1, 
mitochondrial;Pyrroline-5-
carboxylate reductase 
14 -269.862 -266.347 
PYCR2 Pyrroline-5-carboxylate reductase 
2;Pyrroline-5-carboxylate reductase 
12 -297.562 -249.867 
QARS Glutamine--tRNA ligase 14 -128.891 -169.469 
RAI14 Ankycorbin 70 -305.445 -285.716 
RAN GTP-binding nuclear protein Ran 13 -214.778 -244.191 
RANBP2 E3 SUMO-protein ligase RanBP2 93 -175.156 -186.675 
RANGAP1 Ran GTPase-activating protein 1 32 -227.872 -254.439 
RAPH1 Ras-associated and pleckstrin 
homology domains-containing 
protein 1 
15 -202.573 -137.699 
RARS Arginine--tRNA ligase, cytoplasmic 28 -190.644 -204.841 
REPS1 RalBP1-associated Eps domain-
containing protein 1 
11 -271.302 -149.924 
RPL3 60S ribosomal protein L3 19 -132.016 -187.118 
RPL6 60S ribosomal protein L6 13 -16.827 -243.831 
RPL7 60S ribosomal protein L7 15 -191.001 -191.615 
RPL7A 60S ribosomal protein L7a 12 -153.604 -140.148 
RPN1 Dolichyl-diphosphooligosaccharide-
-protein glycosyltransferase subunit 
1 
14 -134.168 -143.952 
RPS2 40S ribosomal protein S2 14 -163.075 -179.206 
RPS3 40S ribosomal protein S3 20 -118.161 -155.881 
RRBP1 Ribosome-binding protein 1 32 -110.061 -173.399 
RUVBL1 RuvB-like 1 21 -349.214 -323.868 
RUVBL2 RuvB-like 2 18 -192.895 -251.548 
SCRIB Protein scribble homolog 19 -189.164 -151.742 
SEC16A Protein transport protein Sec16A 40 -188.646 -188.449 
SEC23A Protein transport protein Sec23A 11 -152.966 -119.044 
SEPT11 Septin-11 15 -226.333 -229.612 
SEPT2 Septin-2 15 -366.345 -37.665 
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SERBP1 Plasminogen activator inhibitor 1 
RNA-binding protein 
16 -110.377 -187.049 
SH3D19 SH3 domain-containing protein 19 14 -230.814 -162.937 
SHMT2 Serine hydroxymethyltransferase, 
mitochondrial;Serine 
hydroxymethyltransferase 
30 -422.523 -383.894 
SIPA1L1 Signal-induced proliferation-
associated 1-like protein 1 
33 -14.058 -153.374 
SIPA1L3 Signal-induced proliferation-
associated 1-like protein 3 
10 -117.325 -114.922 
SLC30A9 Zinc transporter 9 20 -239.775 -210.135 
SMC2 Structural maintenance of 
chromosomes protein 2 
10 -14.097 -110.076 
SMC3 Structural maintenance of 
chromosomes protein 3 
14 -119.067 -101.063 
SND1 Staphylococcal nuclease domain-
containing protein 1 
10 -142.082 -157.209 
SNX1 Sorting nexin-1 13 -152.301 -160.147 
SNX6 Sorting nexin-6;Sorting nexin-6, N-
terminally processed 
18 -231.452 -255.716 
SORBS2 Sorbin and SH3 domain-containing 
protein 2 
18 -188.119 -209.943 
SPAG9 C-Jun-amino-terminal kinase-
interacting protein 4 
15 -169.619 -128.525 
SPECC1 Cytospin-B 11 -250.635 -193.644 
SPECC1L;SP
ECC1L-
ADORA2A 
Cytospin-A 14 -188.854 -24.323 
SPTAN1 Spectrin alpha chain, non-
erythrocytic 1 
59 -20.235 -183.624 
SRP68 Signal recognition particle subunit 
SRP68 
15 -136.145 -112.098 
SSFA2 Sperm-specific antigen 2 16 -175.545 -160.274 
STAT1 Signal transducer and activator of 
transcription 1-alpha/beta;Signal 
transducer and activator of 
transcription 
22 -224.154 -22.623 
STRAP Serine-threonine kinase receptor-
associated protein 
19 -201.403 -188.646 
SUCLA2 Succinyl-CoA ligase [ADP-forming] 
subunit beta, mitochondrial 
10 -224.811 -163.873 
SVIL Supervillin 77 -199.752 -168.121 
SYNJ2 Synaptojanin-2 26 -136.863 -126.309 
SYNPO Synaptopodin 31 -305.565 -226.029 
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TANC1 Protein TANC1 26 -226.868 -300.671 
TCP1 T-complex protein 1 subunit alpha 33 -183.506 -204.216 
TDRD3 Tudor domain-containing protein 3 14 -193.998 -112.743 
TLN1 Talin-1 104 -330.315 -287.229 
TLN2 Talin-2 17 -168.316 -101.861 
TNKS1BP1 182 kDa tankyrase-1-binding 
protein 
26 -163.859 -105.718 
TNS3 Tensin-3 36 -384.765 -381.464 
TP53BP2 Apoptosis-stimulating of p53 
protein 2 
11 -177.863 -136.264 
TRAP1 Heat shock protein 75 kDa, 
mitochondrial 
16 -169.106 -143.098 
TRIM25 E3 ubiquitin/ISG15 ligase TRIM25 12 -176.322 -176.068 
TRIOBP TRIO and F-actin-binding protein 32 -20.373 -226.444 
TRMT10C Mitochondrial ribonuclease P 
protein 1 
14 -164.783 -145.166 
TTC28 Tetratricopeptide repeat protein 28 26 -259.423 -208.884 
UACA Uveal autoantigen with coiled-coil 
domains and ankyrin repeats 
41 -222.465 -252.209 
UBAP2 Ubiquitin-associated protein 2 14 -181.522 -182.383 
UBAP2L Ubiquitin-associated protein 2-like 22 -254.937 -204.979 
UGDH UDP-glucose 6-dehydrogenase 11 -134.806 -102.163 
UNC45A Protein unc-45 homolog A 15 -177.374 -184.467 
UPF1 Regulator of nonsense transcripts 1 14 -20.916 -213.258 
UQCRC2 Cytochrome b-c1 complex subunit 2, 
mitochondrial 
13 -141.939 -153.751 
USP10 Ubiquitin carboxyl-terminal 
hydrolase 10 
12 -145.712 -166.841 
USP15 Ubiquitin carboxyl-terminal 
hydrolase 15 
11 -213.885 -150.422 
USP9X Probable ubiquitin carboxyl-
terminal hydrolase FAF-X 
19 -160.999 -193.159 
UTRN Utrophin 78 -183.743 -15.804 
VARS Valine--tRNA ligase 14 -160.863 -187.086 
VCL Vinculin 36 -154.743 -170.162 
VCPIP1 Deubiquitinating protein VCIP135 18 -205.367 -22.587 
VDAC2 Voltage-dependent anion-selective 
channel protein 2 
11 -153.291 -160.025 
VIM Vimentin 51 -271.615 -273.015 
VWA8 von Willebrand factor A domain-
containing protein 8 
47 -18.039 -160.463 
WDR11 WD repeat-containing protein 11 19 -190.942 -175.176 
XPO1 Exportin-1 13 -14.286 -178.121 
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Gene names Protein names Unique 
peptides 
Ratio H/L 
normalized 
Ratio H/M 
normalized 
XRN1 5-3 exoribonuclease 1 53 -233.105 -234.593 
ZC3HAV1 Zinc finger CCCH-type antiviral 
protein 1 
17 -138.387 -152.957 
ZYX Zyxin 16 -232.265 -179.156 
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